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Effect of air, peroxides and diabetes on antioxidant enzyme localization in red blood cells 
Zornitsa Stoyanova 
 
Red blood cells (RBCs) circulate through the lung and capillaries during their 
120-day life span, transporting oxygen and carbon dioxide. They are exposed 
continuously to reactive oxygen species (ROS) derived from hemoglobin autoxidation. 
Protection of the RBC membrane from ROS is critical since on oxidation the cell loses its 
ability to deform in narrow capillaries. We investigated by Western blotting and confocal 
microscopy membrane recruitment of the key antioxidant enzymes, CuZn-superoxide 
dismutase (CuZnSOD), catalase, peroxiredoxin-2 (Prx2) and glutathione peroxidase-1 
(Gpx1). 
 Prolonged air exposure of human RBCs, which likely increases their O2
●
¯ levels, 
resulted in less membrane-associated CuZnSOD but more membrane-associated catalase 
and Gpx1. Prx2 membrane levels remained unchanged. 
 Challenge with H2O2 or cumene hydroperoxide recruited Gpx1 to the membrane 
to metabolize lipid peroxides. Localization of catalase, which is always present at the 
membrane, remained unchanged but membrane-associated Prx2 decreased after peroxide 
treatment.  
We also investigated membrane recruitment of the antioxidant enzymes in 
diabetic vs control rat RBCs. Notably, CuZnSOD increased at the RBC membrane in 
control animals at 2 versus 4 weeks. We attributed this to the observed increase in PTP1B 
activity, suggesting that CuZnSOD membrane localization is regulated by 
 iv 
 
phosphorylation of the cytoplasmic domain of Band-3 (CDB3). Catalase decreased at 
RBC membranes of 4-week diabetic rats whereas Prx2 levels increased. Gpx1 membrane 
levels did not change in diabetic RBCs suggesting that its membrane binding sites are 
always saturated to protect against lipid oxidation. Our results provide evidence that 























I would like to express my gratitude to my colleagues who shared their 
knowledge and contributed to the successful completion of my MSc degree.   
I would like to thank my supervisor, Dr Ann M. English, for the opportunity to 
join her outstanding research team. In the past two years, I have realized that greater 
synergy is achieved by a diverse group of individuals working together. I acquired solid 
knowledge of basic and advanced biochemical techniques and principles. I learned how 
to apply this knowledge to results obtained in the laboratory and to critically analyze and 
present scientific information. Dr English has a dedication to research and her invaluable 
guidance has prepared me for a successful career in science. 
I would like to thank my research committee members, Dr Heidi Muchall, Dr 
Andreas Bergdahl, Dr Alisa Piekny and Dr William Zerges for their time and 
constructive feedback.  
I would like to express my gratitude to my group members for demonstrating 
professionalism and for sharing valuable skills and knowledge. It has been an honour to 
be a member of this diverse team and I was also energized in this dynamic learning 
environment. Thank you, Mr Marc Ouellet, Dr Maria Shadrina, Mr Dorival Martins, Ms 
Samaneh Dastpeyman, Mr Vinod Parmar, Ms Andrea Clarke, and Ms Meena Kathiresan 
for your consistent support and for a very enjoyable laboratory experience. 
Finally, I would like to thank my family and friends for their support throughout 
the years, and particularly to my very special friend Marika Dochia for her precious 













To my father Mr Nancho Stoyanov and my mother Ms Svetlana Stoyanova 
 
Mom and Dad, thank you for giving me life, for teaching me right from wrong, 
and for providing a loving home. 
You have taught me to pursue my goals with passion, to be independent, to 
respect and be respected. 
I hope to make a difference in the scientific community and change lives. 




Table of contents 
List of Figures........................................................................................................................... x 
List of Schemes .................................................................................................................... xiii 
List of Tables .........................................................................................................................xiv 
List of Abbreviations ............................................................................................................. xv 
Chapter 1:  Introduction ........................................................................................................... 1 
1.1 Organization and function of red blood cells ............................................................. 1 
1.2 Band-3 as major organizer of the RBC membrane.................................................... 2 
1.3 ROS and oxidative stress in RBCs ............................................................................. 5 
1.4 Nonenzymatic antioxidant defence systems in RBCs ............................................. 12 
1.5 Enzymatic antioxidant defence systems in RBCs ................................................... 13 
1.6 Copper, zinc-superoxide dismutase (CuZnSOD) .................................................... 15 
1.6.1 Properties of human CuZnSOD (SOD 1).............................................................. 15 
1.6.2 Superoxide dismutase (SOD) activity of CuZnSOD ............................................ 17 
1.7 Catalase ...................................................................................................................... 17 
1.7.1 Properties of human catalase ................................................................................. 18 
1.7.2 H2O2 decomposition by catalase ............................................................................ 20 
1.8 Peroxiredoxin-2 (Prx2) .............................................................................................. 21 
1.8.1 Properties of mammalian peroxiredoxins ............................................................. 21 
1.8.2 Antioxidant role of RBC Prx2 ............................................................................... 22 
1.9 Structure of Glutathione peroxidases (Gpx) ............................................................ 23 
1.9.1 Antioxidant role of RBC Gpx1 .............................................................................. 25 
1.10 Outline and scope of thesis ....................................................................................... 27 
Chapter 2: Materials and Methods ........................................................................................ 29 
2.1 Materials ..................................................................................................................... 29 




2.3 Antibodies used for confocal microscopy of fixed and stained human RBCs ...... 30 
2.4 Methods ...................................................................................................................... 30 
2.2.1 Quantitation of membrane-associated proteins by Western blotting .................. 30 
2.2.1.1 Human blood collection and washing of RBCs .......................................... 30 
2.2.1.2 Prolonged exposure to air of human RBCs ................................................. 31 
2.2.1.3 Human RBC exposure to H2O2 and cumene hydroperoxide (CHP) .......... 31 
2.2.1.4 Isolation of membranes from human RBCs ................................................ 32 
2.2.1.5 Rat blood collection and washing of rat RBCs ........................................... 33 
2.2.1.6 Isolation of membranes from rat RBCs ....................................................... 34 
2.2.1.7 SDS-PAGE and Western blotting of membrane-associated proteins from 
human and rat RBCs .................................................................................................. 34 
2.2.1.8 Densitometry of membrane-associated proteins from human and rat RBCs
 36 
2.2.1.9 Coomassie staining of PVDF as loading control ........................................ 37 
2.2.1.10 Standard plot preparation ....................................................................... 37 
2.2.2 Localization of proteins in fixed human RBCs by confocal microscopy ........... 38 
2.2.2.1 Preparation of human RBCs ......................................................................... 38 
2.2.2.2 Fixing and permeabilization of human RBCs ............................................. 39 
2.2.2.3 Staining of human RBCs for CuZnSOD, catalase, Gpx1 and Prx2 ........... 40 
2.2.2.4 Confocal microscopy of fixed human RBCs ............................................... 41 
Chapter 3: Characterizing controls for immunoblotting, immunofluorescence and 
hemolysis ................................................................................................................................ 43 
3.1 Standard plot preparation of the detection of CuZnSOD, catalase, Prx2 and Gpx1
..................................................................................................................................... 43 
3.2 Linear range for CuZnSOD, Prx2, catalase and Gpx1 analysis by Western blotting
..................................................................................................................................... 44 
3.3 Sum of Coomassie bands as a loading control in Western blot analysis ............... 48 
3.4 Confocal controls for CDB3 and Hb localization in human RBCs ........................ 49 
3.5 Prx2 visualization in fixed human RBCs ................................................................. 51 
3.6 Determination of most appropriate hemolysis method ........................................... 52 
Appendix 3.1 .......................................................................................................................... 63 
Appendix 3.2 .......................................................................................................................... 65 
Chapter 4: Effects of prolonged air exposure on membrane localization of CuZnSOD, 
catalase, Prx2 and Gpx1 in human RBCs ............................................................................. 67 
4.1 Introduction ................................................................................................................ 67 
 ix 
 
4.2 Results ........................................................................................................................ 68 
4.2.1. CuZnSOD localization after air exposure ............................................................. 71 
4.2.2. Catalase localization after air exposure ................................................................. 71 
4.2.3. Prx2 localization after air exposure ....................................................................... 72 
4.2.4. Gpx1 localization after air exposure...................................................................... 73 
4.3 Discussion .................................................................................................................. 74 
Appendix 4.............................................................................................................................. 77 
Chapter 5 Membrane localization of CuZnSOD, catalase, Prx2 and Gpx1 in human RBCs 
on exposure to H2O2 and CHP .............................................................................................. 81 
5.1 Introduction ................................................................................................................ 81 
5.2 Results ........................................................................................................................ 82 
5.2.1. CuZnSOD localization after peroxide treatment .................................................. 82 
5.2.2. Catalase localization after peroxide treatment ...................................................... 82 
5.2.3. Prx2 localization after peroxide treatment ............................................................ 84 
5.2.4. Gpx1 localization after peroxide treatment ........................................................... 85 
5.3 Discussion .................................................................................................................. 85 
Appendix 5.............................................................................................................................. 89 
Chapter 6: Membrane localization of RBC antioxidant proteins in a diabetic rat model.. 92 
6.1 Introduction ................................................................................................................ 92 
6.2 Results ........................................................................................................................ 93 
6.2.1. CuZnSOD localization in diabetic RBCs.............................................................. 93 
6.2.2. Catalase localization in diabetic RBCs ................................................................. 94 
6.2.3. Prx2 localization in diabetic RBCs........................................................................ 95 
6.2.4. Gpx1 localization in diabetic RBCs ...................................................................... 95 
6.3 Discussion .................................................................................................................. 98 
Appendix 6............................................................................................................................ 101 
Chapter 7: Overall discussion and conclusions .................................................................. 110 






List of Figures 
Fig 1.1 Top and cross sectional view of a red blood cell    1 
Fig 1.2 Two types of multiprotein complexes at the RBC membrane,  
Band-3 and 4.1R complexes       3 
Fig 1.3 Formation of ROS and RBC oxidative damage    8 
Fig 1.4 Crystal structure of human SOD1 homodimer    15 
Fig 1.5 Oxidized and reduced metal-binding sites of bovine CuZnSOD  16 
Fig 1.6 Structure of human catalase       19 
Fig 1.7 Active-site channel of human catalase     20 
Fig 1.8 Mechanism of H2O2 decomposition by Prx2     23 
Fig 1.9 Structure of GSH-dependent Gpx1      25 
Fig 1.10 Mechanism of catalysis by Gpx1      27 
Fig 2.1 Structure of cumene hydroperoxide (CHP)     32 
Fig 2.2 Structure of streptozotocin (STZ)      33 
Fig 2.3 Densitometry measurements       36 
Fig 2.4 Structure of acrolein        39 
Fig 2.5 Excitation (blue) and emission (red) spectra of Cy2 and FITC dyes  42 
Fig 3.1 Determination of the linear region in Western blots of CuZnSOD, 
catalase, Prx2 and Gpx1 in human RBC membranes    45 
Fig 3.2 Standard plots of CuZnSOD, catalase, Prx2 and Gpx1 in isolated 
membranes from human RBCs      46 
Fig 3.3 Four CuZnSOD, catalase, Prx2 and Gpx1 controls to be loaded  
 xi 
 
on each gel for Western blotting      47 
Fig 3.4 Plot of summed band intensities vs total protein per lane   48 
Fig 3.5 Confocal immunofluorescence and corresponding bright field  
images of Hb and CDB3 in fixed intact human RBCs   50 
Fig 3.6 Confocal immunofluorescence and corresponding bright field  
images of Prx2 in fixed intact human RBCs     52 
Fig 3.7 Hb content of membrane fractions from human RBCs varies  
with the phosphate concentration in the hemolysis buffer  
but not after NEM addition       57  
Fig 3.8 Western blot of Prx2 from a non-reducing SDS- PAGE (no  
β-mercaptoethanol) of membrane fractions of human RBCs 
lysed in 10 mM phosphate ± 30 min incubation or 40 mM  
phosphate ± 100 mM NEM       58 
Fig 3.9 Effect of hemolysis method on CuZnSOD, catalase, and 
Prx2 membrane localization       61 
Fig 4.1 Western blots of CuZnSOD, catalase, Prx2 and Gpx1 in  
membrane fractions isolated from human RBC following air 
exposure for 0 min (control), 30 min and 60 min    69  
Fig 4.2 Relative amounts of CuZnSOD, catalase, Prx2 and Gpx1 in  
membrane fractions isolated from human RBC following air  
exposure for 0 min, 30 min and 60 min     70 
Fig 4.3 Confocal immunofluorescence and corresponding bright  
field images of CuZnSOD, catalase, and Gpx1 in fixed intact  
 xii 
 
human RBCs         75 
Fig 5.1 Western blots of CuZnSOD, catalase, Prx2 and Gpx1 in  
membranes isolated from human RBCs treated with 
H2O2 or cumene hydroperoxide (CHP)     85 
Fig 5.2 Relative amounts of CuZnSOD, catalase, Gpx1 and Prx2 in  
membranes isolated from human RBCs treated with H2O2  
or cumene hydroperoxide (CHP)      84 
Fig 5.3 Confocal immunofluorescence images of CuZnSOD, catalase,  
and Gpx1 in fixed intact human RBCs under H2O2 flux   87 
Fig 6.1 Western blots for CuZnSOD, catalase Prx2 and Gpx1 in  
isolated membranes from rat RBCs      96 
Fig 6.2 Densitometry of CuZnSOD, catalase, Prx2 and Gpx1 bands in  
Western blots from control and STZ-treated rat RBCs after  
removal of outliers        97 
Fig 6.3 Comparison of PTP1B activity in membrane fractions from  




List of Schemes 
Scheme 1.1 CuZnSOD-catalyzed dismutation of O2
●
¯ to O2 and H2O2  17 
Scheme 1.2 Two-step mechanism of H2O2 decomposition by catalase  21 




List of Tables  
Table 1.1 Summary of properties for CuZnSOD in human RBCs   13 
Table 1.2 Summary of properties of the three major peroxide-metabolizing  
enzymes in human RBCs, catalase, Prx2 and Gpx1   14 
Table 3.1 Summary of linear regions and optimum protein loaded for  
CuZnSOD, catalase, Prx2 and Gpx1 as determined from  
standard plots in Fig 3.2 and detected by Western blotting   47 
Table 3.2 Total protein controls for Western blotting    47  
Table 5.1 Localization of catalase, Gpx1 and CuZnSOD in human RBCs 
after a steady-state generation of H2O2     86 
 xv 
 
     
List of Abbreviations 
CDB3                    Cytoplasmic domain of Band-3 
CHP   Cumene hydroperoxide 
CpdI                      Compound I   
CuZnSOD             CuZn-superoxide dismutase 
DeoxyHb Deoxyhemoglobin 
GAPDH                Glyceraldehyde 3-phosphate dehydrogenase 
Gpx1                     Glutathione peroxidase-1 
G-PBS                   Glucose phosphate buffered saline 
GSH                      γ-glutamylcysteinylglycine or glutathione 
Hb                         Hemoglobin 
HRP                      Horseradish peroxidase 
Ht                          Hematocrit  
H2O2 Hydrogen peroxide  
MetHb                   Methemoglobin 
MDA                     Malondialdehyde 
NEM N-ethylmaleimide 
OxyHb                  Oxyhemoglobin 
PBS                       Phosphate buffered saline  
PFK Phosphofructokinase 
PMSF Phenylmethylsulfonyl fluoride 
Prx2                       Peroxiredoxin-2  
 xvi 
 
PSS Physiological saline solution 
PTPase Phosphotyrosine phosphatase 
p-NPP p-nitrophenyl phosphate 
RBC                      Red blood cell 





 Chapter 1:  Introduction 
1.1 Organization and function of red blood cells  
Blood is composed of cells and plasma. The most abundant cells in blood are red 
blood cells (RBCs, also called erythrocytes), which contain a high concentration of the 
heme protein hemoglobin (Hb). Hb reversibly binds O2 and greatly increases O2 






Fig 1.1 Top and cross sectional view of a red blood cell. RBC has a biconcave disk shape and is ~2 µm 
thick with ~7 µm diameter. Adapted from http://www.easynotecards.com/print_cards/2967: accessed Mar 
5, 2013 
 
Human RBCs are produced in the bone marrow. As the RBCs emerge from the 
bone marrow to enter the blood, they lose their nuclei, ribosomes, and mitochondria and 
therefore all capacity for cell division, protein synthesis, and mitochondrial-based 
oxidative reactions (1, 2). The anucleated mature human RBC is one of the most 
specialized cells in the body. Human RBCs are small biconcave discs with high surface-





transport from tissues to the lungs (1). Approximately 25x10
12
 RBCs course through the 
human circulatory system. They travel through microcapillaries (1-2 µm in diameter) and 
must undergo extensive deformation and resist fragmentation, which is essential for 
function and survival (3-7). Membrane rigidity is an important factor in reducing cell 
deformability (8) and maintenance of deformability aids in the exit of mature RBCs from 
the bone marrow (9). RBCs cannot divide or maintain their structure for very long and 
have an average lifespan of 120 days (10).  
Plasma constitutes ~ 55% of whole blood and acts as a buffer to maintain human 
arterial blood pH at 7.35-7.45 while RBCs occupy ~ 45% of whole blood. White blood 
cells (WBCs or leukocytes) and platelets, occupy ~ 1% of whole blood. They participate 
in the immune response and blood clotting, respectively (1). 
 
1.2 Band-3 as major organizer of the RBC membrane 
The RBC plasma membrane consists of a lipid bilayer composed of ~50% 
protein, ~40% lipid and ~10% carbohydrate (11) and has a complex organization. It acts 
as a physical barrier, yet it readily passes ions, nutrients and information between the 
cytoplasm and the extracellular environment. Many transmembrane and cytosolic 
proteins are associated with the abundant anion channel protein Band-3, forming a 
metabolon (12). Two types of Band-3 containing multiprotein complexes at the 
membrane have been defined as shown in Fig 1.2. On the left side, tetrameric Band-3 is 
attached to spectrin via ankyrin, which is referred to as the Band-3 complex. On the right 
side of Fig 1.2, dimeric Band-3 interacts with protein 4.1 to form what is known as 4.1R 
 3 
 
complex (13). It has been speculated that the RBC membrane is composed of repeating 












Fig 1.2 Two types of multiprotein complexes at the RBC membrane, Band-3 and 4.1R complexes 
(modified from (15)). (Left) Band-3 complex: the N-terminal cytoplasmic domain of Band-3 (CDB3) 
contains binding sites for many proteins including deoxyHb, hemichromes and the glycolytic enzymes - 
aldolase, phosphofructokinase (PFK), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that 
carbonic anhydrase II (CAII) binds to the short C-terminus of Band-3.  (Right) 4.1R protein complex. (15). 
 
 
Band-3 constitutes the most abundant polypeptide in the RBC membrane, 
comprising 25% of the total membrane protein. Band-3 can be divided into two 
independent structural domains. The 55 kD membrane-spanning domain is thought to 
traverse the bilayer twelve times and serves to catalyze the exchange of anions (mainly 
Cl¯ for HCO3¯ across the membrane during gas transport in the blood (16). The 





circulation (17-19), and it has been shown to carry a number of common blood group 
antigens (20). The external domain of Band-3 contains many attached sugars (20).  
The 41 kDa N-terminal cytosolic domain of Band-3 (CDB3) from human RBCs 
was crystallized and characterized by Zhang et al. in 2000 (21). The first 54 residues at 
the N-terminus and the last 23 residues at the C-terminus at CDB3 were not resolved 
(21). Physical studies of CDB3 have shown a remarkable flexibility of this region (22, 
23). The first 54 residues form a strongly anionic region, containing 20 acidic residues, 
no basic residues and a blocked N-terminal methionine (24, 25). This region is also 
involved in peripheral protein interactions and contains a critical Tyr8 residue which is 
the main site of phosphorylation by protein kinases in the N-terminus of Band-3 (26). 
Included among the protein binding partners of ligands of CDB3 are Hb (35, 36), 
hemichromes (37), the protein tyrosine kinase (p72syk) (38), ankyrin (27), protein 4.2 
(28, 29), protein 4.1 (30, 31), GAPDH (32), PFK (33), and aldolase (34). Interestingly, 
oxidation of Cysβ93 on the β-chain of Hb has been proposed as a specific and sensitive 
marker for oxidative stress during storage (39), but the effect of Cysβ93 oxidation on 
CDB3 binding affinity has not been reported. Note that CAII binds to the short cytosolic 
C-terminal domain of Band-3 and not to CDB3. It was reported that in vitro 
phosphorylation of the human purified CDB3 by a protein-tyrosine kinase (p40) results in 
the inhibition of binding of aldolase, GAPDH, PFK, and Hb, suggesting that CDB3 might 
be involved in regulation of glycolysis (40). Importantly, each of these Band-3 
interactions has nontrivial consequences for the structure and function of the cell, ranging 
from control of cell flexibility and shape (41), to regulation of glucose metabolism (42), 
ion transport (43), and cell lifespan (19). 
 5 
 
1.3 ROS and oxidative stress in RBCs 
Molecular oxygen is beneficial and harmful to living systems. Partially reduced 
forms of O2 are damaging and are collectively termed reactive oxygen species (ROS) 
(44). ROS include the superoxide radical anion (O2
●
¯), the hydroxyl radical (OH
●
) and 
hydrogen peroxide (H2O2).  
During its lifetime, a RBC passes through the human circulation ~75,000 times 
(45) and reversibly binds O2 on each cycle (Fig 1.3, Panel A). As a result of their main 
physiological role, RBCs are subjected to constant oxidative stress. Moreover, the RBCs 
(~7 μm in diameter) need to withstand turbulent flow, and must be deformable to pass 
through capillary beds with 1-2 μm in diameter (46).  In most cells, mitochondria are 
major sources of endogenous ROS (47). Despite their lack of mitochondria, RBCs 
continuously produce ROS because these cells possess high O2 and heme concentrations 
(48). Various factors lead to generation of ROS such as O2
●
¯, H2O2, and OH
●
 in RBCs 
(49). Some exogenous sources of ROS in the blood are the phagocytic cells, neutrophils 
and macrophages (50). 
The main source of ROS in erythrocytes is the O2 carrier protein Hb. This protein 
has two forms (oxyHb and deoxyHb) and undergoes autoxidation. Since the intracellular 
concentration of oxyHb is ~5 mM, even a small rate of autoxidation can produce 
substantial levels of O2
●
¯ with a concomitant formation of metHb (Fig 1.3, Panel B). The 
steady-state concentration of O2
●
¯ inside RBCs is ~10 pM (51). MetHb formation results 
in the loss of the most important task of RBCs (52) because metHb cannot bind and 
transport O2.  During autoxidation an electron is lost from the heme Fe
II







¯ arises due to the effect of an exogenous source 
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such as certain drugs (53) and is capable of attacking the RBC membrane directly and 
causing structural alterations in lipids and proteins (54). Furthermore, dismutation of 
O2
●
¯ readily generates a second ROS, H2O2 (Equation 1.1) (53).  
 
    O2
●
¯   +    O2
●
¯   +   2H
+
                     H2O2   +   O2  
 
 
Superoxide crosses membranes via transmembrane anion channels such as Band-
3, but its uncharged dismutation product, H2O2 (Equation 1.1), crosses membranes by 
passive diffusion (55) or via aquaporin (56). Human RBCs have a limited ability to 
synthesize new proteins to replace damaged ones (57). However, RBCs have strong 
antioxidant defences and H2O2 is not particularly damaging to the membrane and 
molecules within RBCs. Exported H2O2 could be harmful to the extracellular milieu 
because the plasma possesses few antioxidant defences (55). Thus, not only could 
oxidative stress harm the RBC itself, but the exit of large quantities of H2O2 from the 
RBC could damage other components in the circulatory system (58).  
The harmful effects of ROS causing potential biological damage are collectively 
termed oxidative stress. Oxidative stress results from ROS overproduction or a 
weakening of the antioxidant defence system. The most obvious oxidative damage is the 
formation of Heinz bodies. Heinz bodies are composed of denatured Hb and some 
membrane proteins, including Band-3. Although Heinz bodies may form by oxidation of 
internal sulfhydryl groups in Hb (59), hemichrome formation seems more important (37) 
in Heinz body formation. Reversible hemichromes, such as Hb hydroxide and 
bishistidine ferrihemochrome, are formed from metHb (Fig 1.3, Panel C). As the name 




eventually, to reduced Hb. If irreversible hemichromes (bishistidine ferrihemochrome or 
a mercaptide derivative) are formed, Hb denaturation cannot be stopped, and Hb 
aggregates to form hemichromes (60). Hemichromes have an increased affinity for CDB3 
and bind to it (37). The resulting Band-3-hemichrome complex promotes the aggregation 
of additional molecules to form a cluster that can be recognized microscopically as Heinz 
bodies. Because it is an integral protein and spans the lipid bilayer, this also results in 
Band-3 clustering on the outside of the RBC membrane, which creates a recognition site 
for auto-antibodies (17). Auto-antibodies against Band-3 clusters likely play a key role in 
recognizing senescent erythrocytes (61) since RBCs with attached auto-antibodies are 
trapped and degraded by macrophages in the spleen and liver. Heinz bodies can also be 
removed from RBCs by the spleen, and the repaired cells remain in circulation (62), a 
phenomenon known as splenic “pitting”.  
Also, progressive hemichrome formation, oxidation and phosphorylation of Band-
3 have been observed in RBCs under oxidative stress, while in control RBCs Band-3 
oxidation and phosphorylation are transient and no hemichrome formation is observed. 
Hemichromes bind to Band-3 and promote the clustering of phosphorylated Band-3 (63). 
In Fig 1.3, Panel D, O2
●
¯ generated in the production of metHb is converted into 
H2O2 by CuZn-superoxide dismutase (CuZnSOD). Hydroxyl radicals are produced with 
H2O2 and ferrous iron from denatured metHb products functioning as Fenton reagents 
(64).  
ROS can cause lipid peroxidation when OH
●
 attacks polyunsaturated fatty acids 
within the membrane (54) as shown if Fig 1.3, Panel E. Hydroxyl radicals in the 
membrane attack unsaturated lipids to form lipid radicals (CH
●
), then combine with 
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molecular oxygen to form lipid peroxyl radicals (HCOO
●
), which in turn attack 
unsaturated lipid to complete the cycle. Lipid peroxidation leads to altered phospholipid 
fluidity, loss of membrane integrity and loss of cellular homeostasis (48). Also, 















Fig 1.3 Formation of ROS and RBC oxidative damage (taken from Yoshida et al. (64)). Panel A: 
Normal function of Hb-reversible binding of O2 to reduced (ferrous) heme in Hb. Panel B: Auto-oxidation 
of oxyHb to methemoglobin (metHb; ferric) with production of superoxide anion. In a steady-state, 1-2% 
of Hb exists as metHb in the circulation. Panel C: MetHb denatures first to ‘reversible hemichromes’, in 
which conformational distortions are minor and can still be reversed. Reversible hemichromes further 
denature to ‘irreversible hemichromes’, which subsequently dissociate to globins and heme. Panel D: The 





within cells of membrane lipid peroxidation (52) and has been shown to bind to proteins. 
This may result in the impairment of membrane-related functions that could ultimately 
diminish survival. MDA accumulation can affect Band-3 function as well as the function 
of its associated enzymes, such as GAPDH and PFK (49). It might also be involved in 
recruiting certain enzymes to the RBC membrane, such as glutathione peroxidase-1 
(Gpx1), as discussed later.  
ROS not only react with lipids but also with membrane and cytosolic proteins, 
resulting in cellular damage. ROS alter proteins by modifying amino acids such as 
sulfhydryl groups on Band-3 and calcium ATP-ase (Ca-ATPase). Dimer formation and 
tetramer formation is important for the proper function of Band-3 as this protein exists 
primarily as a mixture of dimers and tetramers in its membrane environment (65, 66). 
CDB3 has two oxidizable Cys residues, Cys201 and Cys317, which form an inter-subunit 
disulfide bond upon treatment with an oxidizing agent (21).  Formation of this S-S bond 
is critical for dimerization, tetramerization (67) and the proper function of CDB3. 
Therefore, it is important to prevent ROS accumulation to maintain proper function of 
CDB3 and control Band-3 clustering. 
Among other membrane proteins that are possible targets for oxidants, Ca-
ATPase is also essential for RBC survival. Ca-ATPase contains one or more reactive 
sulfhydryl groups that are susceptible to oxidation with resultant loss of enzyme activity. 
Because this enzyme is critical in maintaining the very steep gradient between 
extracellular and intracellular calcium, loss of activity is associated with decreased 
deformability and premature destruction of RBCs (68). 
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Like RBC membrane proteins, cytosolic proteins, such as Hb, are also susceptible 
to oxidation. Oxidative modifications in oxyHb as a result of H2O2 exposure have been 
proposed to act as selective signals for proteolysis in RBCs (69). In addition to the 
modification of Hb by H2O2, peroxidation may result in Hb crosslinking to membrane 
proteins, such as spectrin and Band-3, and also the aggregation of Band-3 (70, 71) as 
discussed in Fig 1.3, Panel C. Snyder et al. demonstrated that H2O2 induces complex 
formation between spectrin and Hb as well as altered phospholipid organization, RBC 
shape, membrane deformability, and cell surface characteristics (72). The formation of 
crosslinked spectrin and Hb causes the RBC membrane to become more rigid, less 
deformable and less adaptable (72). Thus, protection of the RBC membrane is essential to 
prevent hemolysis which increases in cells with rigid membranes (73). Loss of membrane 
flexibility has profound implications because the survival of many other cells depends 
upon the proper functioning of RBCs.  
When blood is stored under blood bank conditions, RBCs slowly lose their ability 
to survive following transfusion (74). Although preservation of adenosine 5‘-triphosphate 
(ATP) levels lengthen storage time, the ATP concentration is not the major determinant 
of proper RBC function. Erythrocyte membrane function seems to be abnormal in stored 
blood. The in vitro ability of spectrin to bind to actin in the presence of membrane protein 
4.1 decreases during blood storage. The membrane changes that occur in stored RBCs are 
partially reversed by dithiothreitol, suggesting sulfhydryl oxidation. Erythrocytes also 
lose phospholipids during storage, and that loss correlates with Hb leakage. 
Current blood storage practices are known to cause oxidative damage to RBCs, 
known as “storage lesion” that may alter their biological function, including delivery of 
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O2 to cells (75). In clinical settings, blood is stored in air-permeable bags for 42 days (76) 
at 4 ºC but deformation of the RBC membrane due to oxidation occurs after only five 
days of ambient air exposure (77). Accumulation of oxidized Hb and the formation of 
crosslinks between Hb and membrane proteins were recently demonstrated in RBCs 
subjected to prolonged hypothermic storage at 4 ºC (78). Another study demonstrated the 
progressive linkage of catalase and Prx2 to RBC membranes together with non-reducible 
membrane crosslinking of Hb after blood storage for 28 days (79). Thus, growing 
evidence indicates the involvement of oxidized Hb and protein re-localization in 
degenerative processes pertaining to blood storage and draws interest to the fields of 
transfusion medicine and blood banking.  
Diabetes also causes oxidative stress in RBCs (80). Diabetes results in decreased 
RBC membrane fluidity and loss of flexibility, due to the in vivo glycation of proteins as 
well as to changes in lipid composition (81). Glycated proteins include Hb and the 
membrane proteins, ankyrin, actin, and spectrin (82). This modification of Hb and 
membrane proteins by glucose is non-enzymatic and depends on blood glucose levels as 
well as erythrocyte age (82). The glycation of Hb increases its oxygen affinity and makes 
it more susceptible to oxidation (83). 
In humans, oxidative stress is involved in many pathological conditions, including 
atherosclerosis, hypertension, Parkinson’s disease, nephropathy, inflammatory arthritis 




1.4 Nonenzymatic antioxidant defence systems in RBCs 
The antioxidant system in human RBCs consists of non-enzymatic and enzymatic 
pathways. The non-enzymatic defences inside RBCs can be divided into lipophilic 
(vitamin E, vitamin A, ubiquinone, melatonin) and water-soluble compounds (vitamin C, 
glutathione, uric acid). Three antioxidant vitamins A, C, E provide defence against 





radicals and participates in the recycling of vitamin E (48, 85). Vitamin C has been 
shown to play a protective role against peroxidation of RBC membrane lipids and 
vitamin E by t-butylhydroperoxide (tert-B-OOH), preserving lipids by up to 92% (86). 
Vitamin E is the most widely distributed antioxidant in nature. When vitamin E donates 
an electron to a lipid peroxyl radical, it is converted to free radical stabilized by 
resonance structure (87). Vitamin C and E work together to inhibit lipid peroxidation 
reactions in plasma lipoproteins and membranes. Vitamin A is a potent free radical 
scavenger (48) and addition of vitamin A in vitro to erythrocyte membranes has been 
shown to decrease lipid peroxide production.  
GSH (γ-glutamylcysteinylglycine, or glutathione) is the most important 
nonenzymatic, peptidic regulator of intracellular redox homeostasis. GSH is the major 
antioxidant in RBCs since it prevents disulfide formation in important structural proteins 
such as spectrin, which leads to increased membrane stiffness (88). GSH not only 
supports antioxidant defence, but is also an important sulfhydryl buffer, maintaining –SH 
groups in Hb and enzymes in the reduced state (48).  
GSH is present at high levels (~5 mM) in RBCs. It protects against oxidative 
damage by directly interacting with H2O2 and organic peroxides, or as a substrate of 
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detoxification enzymes like Gpx. Importantly, GSH plays an essential role in maintaining 
a constant redox environment inside the RBC that is critical for the function of cellular 
proteins. GSH exists either in reduced GSH or oxidized GSSG forms and participates in 
redox reactions by the reversible oxidation of its active thiol. Inside cells GSH is 
predominantly present in the reduced form (89). Maintenance of high GSH-to-GSSG 
ratio is important in RBCs as it protects against oxidative stress. 
 
1.5 Enzymatic antioxidant defence systems in RBCs 
In addition to non-enzymatic defences, RBCs also rely on abundant antioxidant 
enzymes including CuZnSOD, catalase, Prx2 and Gpx1. CuZnSOD rapidly dismutates 
O2
●
¯ to H2O2 (Table 1.1), which is a substrate for catalase, Prx2 or Gpx1. The latter three 
enzymes react rapidly with H2O2, organic hydroperoxides or lipid peroxides (Table 1.2) 
and whether they carry out nonredundant functions is a matter of considerable debate. 
Catalase degrades H2O2 without consuming cellular reducing equivalents (NADPH), 
which is an energy efficient way of removing H2O2. In addition to catalase, Prx2 and 
Gpx1, RBCs contain glutaredoxin and glutathione S-transferase, which can act as 
peroxidases themselves, but at much slower rates (90). 
















Km 0.0029 mM 





MW monomer  / 
# amino acids monomer 
16 kDa / 153 aa 
Copies per RBC / Concentration 2.7 x 10
5  




Table 1.2 Summary of properties of the three major peroxide-metabolizing enzymes in human RBCs, 















The altered activities of these antioxidant enzymatic systems have been documented 
during oxidative stress conditions, making them reliable markers of oxidative stress. 
Ample experimental reports exist in support of the elevation of oxidative stress during 
redox imbalance leading to the development of a number of pathological changes in 
RBCs (88). A significant decrease in the activities of enzymatic antioxidant defence 
system has also been reported in diabetic patients (89). 





















































Km 25 mM <0.001 mM (for H2O2) 0.24 mM (for H2O2) 


















 (for tert-B-OOH) 
MW monomer / 
# amino acids 
monomer 
60 kDa / 527 aa 22 kDa / 198 aa 23 kDa / 203 aa 













 copies / 6.7 µM 
Reducing 
substrate 
H2O2 Thioredoxin GSH 
 
a 
k2 = bimolecular rate constant for reduction/oxidation of enzyme by the substrate L-OOH, linoleic acid 
hydroperoxide; tert-B-OOH, tert-butyl hydroperoxide 
 15 
 
1.6 Copper, zinc-superoxide dismutase (CuZnSOD) 
The SOD family of enzymes is comprised of three major classes based on the metal 
cofactor. The first class contains Cu and Zn at the active site, the second class contains Fe 
or Mn, and the third class contains Ni. Three forms of SOD are present in humans: SOD1 
is found in cytosol (Cu and Zn at active site), SOD2 is found in the mitochondrion (Mn at 
active site) and SOD3 is extracellular (Cu and Zn at active site). The best known function 
of SOD is the protection of cells from ROS, particularly O2
●
¯ (Equation 1.1). 
1.6.1 Properties of human CuZnSOD (SOD 1) 
Human RBCs contain only CuZnSOD (SOD1) which is a 32 kDa homodimer with 
one Cu- and one Zn-binding site per 153–residue subunit (Fig 1.4). The distance between 
the two active sites in the homodimer is over 30 Å. Each monomer is essentially a β-
barrel with two functional loops, called the electrostatic and zinc loops, which encase the 
metal-binding region. This region of CuZnSOD is fully contained within each subunit 
and the Cu and Zn are in close enough proximity to share an imidazolate ligand, His63 
(Fig 1.5). The two subunits are held together primarily by hydrophobic interactions and 
an intrasubunit disulfide bond as shown in red in Fig 1.4. 
 
Fig 1.4 Crystal structure of human SOD1 
homodimer (PDB ID: 2C9S) (adapted from 
(90)). Copper and zinc ions are shown as blue 
and orange spheres, respectively. The zinc loop 
is depicted in orange and the electrostatic loop in 






The Cu and Zn ions have catalytic and structural roles respectively in CuZnSOD. 
In the oxidized cupric (Cu
II
) form of the enzyme, the copper
 
is bound to four His 
residues, His63, His46, His48, and His120, and a water molecule (Fig 1.5). In the 
reduced cuprous (Cu
I
) form of the enzyme, the copper undergoes a 1.3 Å shift in position, 
moving away from the bridging His63 and releasing the water ligand, thereby switching 
from an irregular five-coordinate geometry to a nearly trigonal planar three-coordinate 
configuration. At the same time, the bridging imidazolate of His63 becomes protonated 




Fig 1.5 Oxidized and reduced metal-binding sites of bovine CuZnSOD (SOD1) (taken from ref (90)). 







is five-coordinate and is bound to four His and one water molecule. In the reduced (bottom, from 
PDB ID: IQ0E) the imidazolate bond is broken between the bridging His63 and Cu
I
, which is bound to 
three His side chains only.  
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1.6.2 Superoxide dismutase (SOD) activity of CuZnSOD 
RBCs are well protected against ROS by CuZnSOD, which is abundant (1.8 – 10 
µM) and efficiently scavenges O2
●
¯ (Table 1.1). In nucleated cells, CuZnSOD synthesis 
is induced by O2
●
¯ and also its activity is increased in the presence of O2
●
¯ with 
activation of regulatory genes (49). CuZnSOD is very stable and its activity is pH-
independent in the range of 5.0 to 9.5 (90).  
A two-step dismutation of O2
●
¯ to O2 and H2O2 (84) (Equation 1.2) occurs at the 




 to form O2 and 




 to form H2O2.  The enzyme’s catalytic 
cycle is described as a ping-pong mechanism (92) (Scheme 1.1). Under non-saturating 
conditions, the rate-limiting step in the dismutation is the diffusion of O2
●
¯ to the active-
site cavity. Based on the estimated diffusion rates of O2
●
¯ and CuZnSOD, the catalytic 

















Catalase catalyzes the decomposition of H2O2 to water and oxygen and is found in 
most aerobic organisms. It was first reported in 1811 in living tissue as the molecule 








1969, the amino acid sequence of bovine liver catalase was determined (96), and by 2004 
over 300 catalase sequences were available (97).  
Catalases can be organized into four main groups (98). The first group is most 
widespread and includes monofunctional, heme-containing enzymes, which are 
subdivided based on subunit size (>75 kDa or <60 kDa) (97). The second group is 
comprised of bifunctional, heme-containing catalase-peroxidases. Third group is 
nonheme or Mn-containing catalases. The fourth group includes miscellaneous proteins 
with minor catalatic activities.  
1.7.1 Properties of human catalase 
Human catalase, a homotetramer of 60-kDa subunits (Fig 1.6A), belongs to the 
group of monofunctional catalases. Each subunit contains an active-site heme 
(ferriprotoporphyrin IX) and requires a NADPH cofactor. One NADPH molecule binds 
per monomer to a pocket located ~19 Å from the heme (99). Two dimers assemble to 
form the tetramer, which is roughly square with overall dimensions of 100 Å x 100 Å x 
70 Å (Fig 1.6B) (99). Tetramerization forces the threading arms from the arm-exchanged 
dimer to cover the hemes in the other dimer. Tetramerization is likely critical for 
sequestering the hemes allowing the enzyme to complete its reaction cycle rather than the 
generation of OH
●
 from exposed hemes (99). 
The heme is at the bottom of a 25-Å channel extending from the enzyme’s 
surface. A 3-Å-wide hydrophobic constriction, lined by the side chains of Val74, Val116, 
Phe153, Phe154, and Trp186 (Fig 1.7), is located directly above the heme. Thus, only 
H2O or other small molecules can reach the heme. Throughout the catalase structure, H2O 
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fills packing defects in each subunit, and between subunits within the tetramer. At either 
end of the hydrophobic constriction, well-ordered H2O molecules form hydrogen bonds 
to the protein, which promotes selection of H2O2 (99). This is known as ‘molecular ruler 
recognition’ mechanism for H2O2. 
Human catalase is a very stable enzyme and works at an optimum physiological 
temperature of 37 °C (100). When the solution pH falls outside the range of 3.5-11, the 
heme dissociates from the active site and catalase loses its enzymatic activity (101). 






























































































Fig 1.6 Structure of human catalase (pdbID: 1QQW). (A) Stereo view of an individual subunit with 
active-site heme in red. (B) Stereo view of the catalase tetramer. Note that formation tetramer formation 
buries the hemes from the solvent. Tetramerization forces the threading arms from an arm-exchanged dimer 











Fig 1.7 Active-site channel of human catalase (taken from ref (99)). A 25-Å channel leads from the 
enzyme’s surface to the heme active site and forms a hydrophobic constriction 3-Å wide immediately 
above the heme. Side chains making up the hydrophobic channel and the proximal Tyr358 ligand are 
displayed in green. The backbone is shown in white, water in red, and the heme in dark red. 
 
1.7.2 H2O2 decomposition by catalase 
Catalase catalyses the dismutation 2H2O2 → 2H2O + O2 (Scheme 1.2) and 
removes H2O2 from RBCs, protecting them from oxidative stress. The first step involves 
oxidation by H2O2 of the heme iron to form compound I (Cpd I), an oxyferryl group with 
a cationic porphyrin radical. In the second step, reduction of Cpd I regenerates the 
resting-state enzyme (Enz) by reacting with another H2O2 molecule (99). 
In RBCs, catalase functions alongside other systems including Gpx1 and Prx2 to 






exposing them to H2O2 has been found to be inversely proportional to their catalase 
content (101), suggesting that catalase is a critical enzyme in the defence against 















Scheme 1.2 Two-step mechanism of H2O2 decomposition by catalase. The first step involves oxidation 
of the heme iron by H2O2 to form compound I (Cpd I). In the second step, Cpd I is reduced back to the 
resting enzyme (Enz) (99). 
 
 
1.8 Peroxiredoxin-2 (Prx2)  
1.8.1 Properties of mammalian peroxiredoxins 
The peroxiredoxins (Prxs) constitute a family of homodimeric peroxidases that 
reduce H2O2 and alkyl hydroperoxides to water and alcohol, respectively. They rely on a 
conserved cysteine residue to catalyze peroxide reduction. There are six known 





based on the mechanism and number of Cys residues involved in catalysis (102). It has 
been suggested that overoxidation of the active-site Cys to sulfinic (-SO2H) or sulfonic 
acid (-SO3H) allows intracellular accumulation of H2O2, which can then function as a 
signal transducer for various pathways, also known as the floodgate hypothesis (103, 
104).  
1.8.2 Antioxidant role of RBC Prx2 
All six isoforms except Prx3 exist in human RBCs (105). Prx2 is the third most 
abundant RBC protein after Hb and carbonic anhydrase (106) and has previously been 
called calpromotin for its ability to regulate calcium-activated potassium efflux (107). For 
a long time, it was considered that catalase and glutathione peroxidase-1 (Gpx1) 
constitute the erythrocyte’s defence against H2O2, and there has been continuous debate 
about which of these is the more significant in H2O2 metabolism (108-113). Recently, it 
was found that modeling peroxide metabolism in Gpx-deficient erythrocytes required the 
inclusion of Prx2 to fit the data (58). It has also been shown that circadian oscillation of 
Prx2 oxidation occurs in human RBCs (105). Prx2 is able to protect Hb from exogenous 
oxidation (114) and is thought to remove peroxides at the RBC membrane (115).  
When Prx2 (a typical 2-Cys Prx) reacts with peroxide, the peroxidatic cysteine (Sp) 
at the active site on one subunit is oxidized to a sulfenic acid (-SpOH) (Fig 1.8). A second 
conserved cysteine at the C-terminal end of the other subunit (the resolving cysteine, SR) 
then reacts with the sulfenic acid to form a disulfide bridge. Reduction of the disulfide by 
thioredoxin (Trx) regenerates Prx2 and completes the cycle. Trx is in turn regenerated by 
thioredoxin reductase (TrxR), with reducing equivalents derived from NADPH (116). 
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RBCs are notable among other cells because they are highly resistant to Prx2 
overoxidation to sulfinic acid (-SpO2H) (117). Also, low TrxR activity has been reported 
in RBCs (117) and has been speculated that Prx2 accumulates as a dimer. In its dimeric 





transport (117). This is in contrast to other mammalian Prxs, which are 
overoxidized to -SpO2H or sulfonic acid (-SpO3H) by high levels of peroxide (118). 











Fig 1.8 Mechanism of H2O2 decomposition by Prx2 (modified from ref (120)). One of two active sites 
within a functional dimer is shown. SP and SR (red) designate the sulfur atoms of the peroxidatic and 
resolving cysteines, respectively. Note that Sp and SR come from different subunits within the dimer.  
 
1.9  Structure of Glutathione peroxidases (Gpx)  
The term Gpx was introduced by Mills in 1957. He discovered peroxidase activity 
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protect RBCs against hemolysis by oxidation. Bovine Gpx1 was identified as the first 
selenoprotein to be discovered (122). Of the numerous mammalian Gpx isoforms only 
four or five have a selenocysteine (Sec) at the active site, and the rest possess a Cys 
residue (123). In 1992, Rocher et al. showed that a selenocysteine to cysteine substitution 
significantly reduces Gpx activity and that a serine mutant is completely inactive (124). 
Furthermore, among the numerous Gpx isoforms that have been identified in all domains 
of life, non-mammalian Gpxs usually have a Cys at the active site (125). The various Gpx 
isoforms use either Trx or GSH as reducing substrate (126).  
Gpx1, the most abundant of the four mammalian types, is found in the cytosol of 
nearly all mammalian cells including RBCs. In all species, Gpx1 is a homotetramer with 
four spherical subunits, each with an active-site Sec in a depression near the surface 
(127). Gpx1 or cytosolic Gpx rapidly metabolizes H2O2 and organic peroxides, including 
cholesterol and lipid peroxides (128). The reducing substrate for Gpx1 is GSH. Gpx2, a 
cytosolic gastrointestinal tetrameric enzyme, has ~65% amino acid sequence identity 
(129) and similar substrate specificity to Gpx1 (130). Gpx3 is an extracellular tetrameric 
glycoprotein (131) with ~50% homology to human Gpx1 (132). It has activity against 
phospholipid hydroperoxides, suggesting a role in the protection of RBC membrane 
extracellularly (133). Gpx4 is a monomer and has a high preference for phospholipid 
hydroperoxides (134).  
Several important structural features of Gpx1 are shown in Fig 1.9. Helix α2 
contributes to the monomer–monomer contact site in crystallized homotetrameric Gpx1 
(127). Moreover, the α2 helix often contains a cysteine residue and is termed the Cys 
block (135), because it is mechanistically relevant for Trx-dependent Gpx-isoforms, such 
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as yeast Gpx2 (136). The active-site Sec residue is found at the N-terminal end of helix 
α1. Another Cys residue in a FPCN-motif at the end of strand β2 is highly conserved 
among all Gpx classes but its role remains unclear (137). The oligomerization loop 
covers a part of the active site and mediates the contact between two dimers in 










Fig 1.9 Structure of GSH-dependent Gpx1 (taken from ref (126)). View along the 2-fold axis of two 
subunits of homotetrameric Gpx1. Two subunits interacting with the so called oligomerization loops are 
omitted. The selenocysteine (Sec) residue is highlighted and further structural elements are labelled.  
 
1.9.1 Antioxidant role of RBC Gpx1 
Gpx1 is the only Gpx isoform present inside RBCs (138). The physiological role 
of Gpx1 in RBCs is difficult to evaluate because Prx2 and catalase also decompose H2O2 
in RBCs. Although Gpx1 shares its substrate, H2O2, with catalase and Prx2, Gpx1 can 
also react with lipid and other organic hydroperoxides.  
Gpx1 has been suggested to be a minor antioxidant in RBCs since the RBCs of 






physiologic substrate of Gpx1 in mouse RBCs may be lipid hydroperoxide rather than 
H2O2 (139, 140). Humans deficient in RBC Gpx1 activity demonstrate hemolysis (141), 
suggesting that Gpx1 might be more important in human than mouse RBCs. Lipid 
oxidation is low in normal RBCs because the O2
●
¯ and H2O2 produced as a result of Hb 
autoxidation are removed efficiently by CuZnSOD and Prx2, respectively. However, in 
diseased states such as Sickle cell disease, the rate of Hb autoxidation is increased, the 
activity of CuZnSOD and Gpx1 is decreased (142, 143), and Prx2 is partially inactivated 
as a result of overoxidation to –SO2H (143), all of which may promote lipid peroxidation.  
Kinetic measurements revealed that Gpx1 acts via a ping-pong mechanism (144). 
There is no ternary complex between Gpx1, the hydroperoxide and GSH, and the reaction 
can be subdivided to an oxidation half-reaction and reduction half-reaction. During the 
oxidation half-reaction, the active-site Sec is deprotonated to a selenolate (E-Se¯, pKa = 
5.47) (145) and acts as a nucleophile. Its activation depends on the side chains of three 
proximal residues Gln, Trp and Asn, whose precise role remains unclear (123). After the 
highly reactive anionic nucleophile is formed (Fig 1.10), the substrate (H2O2, ROOH or 
lipid hydroperoxide) is irreversibly turned over. Based on the high reactivity of the 
active-site Sec, it was suggested that no real binding site for the hydroperoxide substrate 
exists, explaining the rather low substrate specificity (123). The oxidative half-reaction 
ends with the release of H2O or alcohol (ROH), depending on the substrate (Fig 1.10). A 
conformational change has been proposed to occur at the end of this step to position the 
active site in the correct orientation.  
During the reduction half-reaction after formation of the unstable selenenic (E-
SeOH) or sulfenic acid, the first GSH molecule enters the active site and is turned over 
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yielding a water molecule as the second product (Fig 1.10). Since Gpx1 is highly specific 
for GSH (123), there has to be a defined GSH-binding site. However, a structure of a 
GSH-Gpx1 complex has not been solved to date. A second GSH molecule binds to Gpx1, 
yielding GSSG as the third product (Fig 1.10). It is not well understood which GSH 
molecule occupies which surface area during the catalytic mechanism. 
 



















Fig 1.10 Mechanism of catalysis by Gpx1 (modified from (127)). During the oxidation half-reaction of 
Gpx1, the selenolate form of the enzyme (E-Se¯) reacts with peroxides (ROOH) to give the selenenic acid 
(E-SeOH), which is trapped by a GSH molecule to form E-Se-S-G (first reduction half-reaction). During 
the second reduction half-reaction, the E-Se-S-G is reduced back to E-Se¯ by another GSH molecule and 
GSSG is released as a by-product (146). 
 
1.10  Outline and scope of thesis 
The antioxidant enzymes, CuZnSOD, catalase, Prx2 and Gpx1 are critical for 










protection against pathological conditions. Since enzyme localization often determines its 
function, understanding the properties and specific roles of these four RBC enzymes is 
essential. Thus, cell fractionation, quantitative Western blotting and immunofluorescence 
are used here to determine localization of CuZnSOD, catalase, Prx2 and Gpx1 in human 
RBCs.  
This chapter provides background on RBCs and the harmful effects of ROS on 
RBCs. Also, an overview of nonenzymatic and enzymatic antioxidant defences in RBCs 
is presented, followed by a more detailed description of the properties and function of 
CuZnSOD, catalase, Prx2 and Gpx1.  
Chapter 2 describes the two main techniques and the materials used in this study. 
The first technique involves fractionation of RBCs into cytosolic and membrane fractions 
followed by isolation and quantitation of RBC membrane-associated proteins by Western 
blotting. The second technique described is the preparation, fixation, membrane 
permeabilization by detergent addition and staining of RBCs for their visualization by 
confocal microscopy. The treatment of the RBC by different agents, such as prolonged 
air, H2O2, and CHP is also outlined in detail.  
Standard plot preparation for each antioxidant protein, loading controls, and 
confocal controls are discussed in Chapter 3. Results for the membrane localization of 
CuZnSOD, catalase, Prx2 and Gpx1 in RBCs exposed to air for 30 or 60 min and H2O2 or 
CHP are discussed in Chapter 4 and 5, respectively. Chapter 6 provides the results for 
membrane localization of RBC proteins from diabetic rat RBCs. 




Chapter 2: Materials and Methods 
2.1 Materials  
Tris-HCl and Tris base were purchased from MP Biomedicals, Canada. Ultrapure 
potassium phosphate (K2HPO4, monobasic) was from Anachemia, Canada. Glycine, 
sodium dodecyl sulphate (SDS), tetramethylethylenediamine (TEMED), ammonium 
persulphate (APS) and glycerol were from Bioshop, Canada. Proteins were denatured by 
2-mercaptoethanol from Schwarz/Mann Biotech, USA. Bromophenol blue, Tween-20, 
butan-1-ol, methanol (HPLC grade), SuperSignal West Pico Chemiluminescent Substrate 
(ECL kit # 34077) were from Fisher Scientific, Canada. Acrylamide/Bis (29:1) was from 
BioBasic, Canada. Phosphate-buffered saline (PBS) tablets (one tablet was dissolved in 
200 mL of deionized water to give 137 mM NaCl, 2.7 mM KCl, 8.1 mM K2HPO4, 1.5 
mM KH2PO4 at pH 7.4), potassium phosphate (K2HPO4, dibasic), Triton-X, fish skin 
gelatin, sodium azide, polylysine, acrolein were from Sigma, USA. Glucose was from 
EMD Millipore, USA. Aqua-mount was from Lerner Laboratories, USA. All the 
chemicals were analytical grade. Novex MiniCell transfer system was from Invitrogen, 
Canada. The hemocytometer was purchased from Hausser Scientific, USA. 
 
2.2 Antibodies used for Western blotting of isolated membranes from human and 
rat RBCs  
The primary antibodies used were rabbit polyclonal anti–human CuZnSOD 
(#SOD-100) at 1:1000 dilution from Stressgen, USA. Sheep polyclonal anti-human 
catalase (#ab8954, 1:1000 dilution), sheep polyclonal anti-Gpx1 (cat #ab8850, 1:1000 
dilution) and rabbit polyclonal anti-human Prx2 (cat #ab15572, 1:10000 dilution) were 
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from Abcam, United Kingdom. Secondary antibodies used were HRP-conjugated goat 
polyclonal anti-rabbit (cat #1706615, 1:3000 dilution) from Biorad and HRP-conjugated 
donkey polyclonal anti-sheep (cat #ab6900, 1:3000 dilution) also from Abcam, United 
Kingdom.  
 
2.3 Antibodies used for confocal microscopy of fixed and stained human RBCs 
 Rabbit polyclonal anti-human CuZnSOD (#SOD-100) was from Stressgen, USA. 
Mouse monoclonal anti-human CDB3 (ab11012), rabbit polyclonal anti-human 
peroxiredoxin-2 (Prx2, ab15572, IgG fraction), sheep polyclonal anti-human hemoglobin 
(Hb, ab35306, IgG fraction), sheep polyclonal anti-human catalase (ab8954, IgG 
fraction), and sheep polyclonal anti-human glutathione peroxidase-1 (Gpx1, ab8850, IgG 
fraction) were from Abcam, United Kingdom. Cy2-(711-226-152) conjugated donkey 
anti-rabbit, FITC-(713-096-147) conjugated donkey anti-sheep and Cy2-(715-226-150) 
conjugated donkey anti-mouse were from Jackson ImmunoResearch, Canada. All the 
secondary antibodies were supplied as affinity purified.  
 
2.4 Methods 
2.2.1 Quantitation of membrane-associated proteins by Western blotting  
2.2.1.1 Human blood collection and washing of RBCs 
All procedures involving the collection of human blood samples from healthy 
female volunteers 25-35 years old were approved by Concordia’s Human Research 
Ethics Committee. All blood donors provided their informed consult. Blood was drawn 
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with the use of a tourniquet into heparin-coated BD Vacutainer tubes (Fisher Scientific) 
from the antecubital area of the arm and gently mixed by reversing the vial several times. 
Heparin has been established as an appropriate coagulant with minimal effects on RBC 
properties (147). The collected blood was maintained at 4 ºC in a sealed vial and 
processed within 1 h. About 18 mL whole human blood was centrifuged at 1800 xg (4400 
rpm, MicroMax RF Centrifuge, Thermo IEC) for 6 min at 4 ºC. After removal of the 
upper layer (plasma and buffy coat) by pipette, the RBC pellet was washed three times in 
isotonic glucose-PBS (G-PBS) (137 mM NaCl, 2.7 mM KCl, 8.1 mM K2HPO4, 1.5 mM 
KH2PO4, pH 7.4 containing 5 mM D-glucose). At the end of this step, about 9 mL of 
washed RBCs were obtained. G-PBS was added to adjust the number of washed RBCs to 
3x10
8 
cells/mL with a hemocytometer.  
2.2.1.2 Prolonged exposure to air of human RBCs 
Washed RBCs (500 µL at 3x10
8
cells/mL) were exposed to air for 30 or 60 min at 
37 ºC in 500 µL Eppendorf tubes. All tubes were filled to the top and gently stirred 
during incubation. Control samples were not exposed to air and the RBCs were lysed 
immediately following washing. To prevent unwanted disulfide-induced dimer formation 
during handling of Prx2, 15 min incubations at 37 ºC with NEM (N-ethylmaleimide), an 
alkylating agent at 100 mM final concentration, was performed prior to RBC hemolysis 
(117).  
2.2.1.3 Human RBC exposure to H2O2 and cumene hydroperoxide (CHP) 
Washed intact human RBCs (500 µL at 3x10
8
 cells/mL) were treated with a 5-µL 
bolus of 5 mM H2O2 or CHP to give 50 µM final concentration of H2O2 or CHP. G-PBS 
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(5 µL) was added to control samples. CHP is not a substrate for catalase. The experiment 
was carried out in 500 µL Eppendorf tubes which were closed and gently stirred during 




Fig 2.1 Structure of cumene hydroperoxide (CHP) 
2.2.1.4 Isolation of membranes from human RBCs 
Following treatment and NEM alkylation, human RBCs were quickly transferred to 
25-mL centrifuge tubes and lysed by 1:15 dilution into 40 mM hypotonic sodium 
phosphate buffer with 0.1 mM PMSF (phenylmethylsulfonyl fluoride), a serine protease 
inhibitor, pH 7.4 at room temperature. The hypotonicity of this buffer, the pH and 
dilution were carefully chosen as detailed in Section 3.6 and have been documented as 
optimal for localization of RBC membrane-associated proteins and membrane-bound Hb 
(148). The hemolysates were immediately centrifuged at 30,000 xg (14,800 rpm) in 
Beckman J2-HS centrifuge (JA-17 rotor) at 4 ºC and membrane fractions were isolated 
and resuspended in 100 µL of hemolysis buffer (40 mM sodium phosphate, pH 7.4, 0.1 
mM PMSF).  
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2.2.1.5 Rat blood collection and washing of rat RBCs 
This study was performed in collaboration with Dr Andreas Bergdahl and the rats 
used in this study were handled by his laboratory in accordance with the guidelines of the 
Canadian Council of Animal Care (approved by the Concordia University Animal Care 
Committee). In this study, 65 mg streptozotocin (STZ)/kg body weight was injected once 
into the tail vein of five Wistar male rats of the same age and weight (3 months old, ~500 
grams). Saline solution was injected into the tail vein of 5 control animals. Blood glucose 
was monitored and the STZ-treated animals had >15 mM blood glucose at 48 h after 
injection vs <5 mM for the control animals. Animals were euthanized by CO2 
asphyxiation and the bloods, collected by cardiac puncture at 2 weeks and 4 weeks after 







Fig 2.2 Structure of streptozotocin (STZ) 
 
Following collection, the rat blood was donated to our laboratory and maintained at 
4 ºC in a sealed vial and processed within 1 h. Whole blood was centrifuged at 1000 xg 
(3300 rpm, MicroMax RF Centrifuge, Thermo IEC) for 2 min at 4 ºC. After removal of 
the upper layer (plasma and buffy coat) by pipette, the RBC pellet was washed two times 
in isotonic physiological saline solution (PSS, 21 mM Tris base, 7.8 mM NaCl, 0.25 mM 








KCl, 0.1 mM CaCl2, 2.5 µM MgCl2, 0.1 mM NaH2PO4, 0.5 mM HEPES, 7.5 µM BSA, 5 
mM D-glucose). PSS buffer was used to wash the rat RBCs instead of G-PBS because G-
PBS lysed the rat RBCs. PSS has been established as an appropriate buffer for washing of 
rat RBCs (149-151). The number of washed RBCs was counted with a hemocytometer 
and adjusted to 4x10
8
 cells/mL. 
2.2.1.6 Isolation of membranes from rat RBCs 
Washed rat RBCs were lysed by a 15-fold dilution into lysis buffer (10 mM 
hypotonic sodium phosphate buffer, pH 7.4, 0.1 mM EDTA, 1x cocktail inhibitor) at 
room temperature. The hemolysates were incubated on ice for 30 min and centrifuged at 
21,000 xg (12,400 rpm) on Beckman J2-HS with a JA-17 rotor at 4 ºC. To obtain Hb-free 
solubilized membranes (“white ghosts”), the pelleted membranes were washed three 
times with the lysis buffer. The non-ionic detergent, Triton-X at a final concentration of 
0.5% was added to the ~100 µL pelleted membrane to solubilize the proteins in a final 
volume of 300 µL. For example, to obtain a final volume of 300 µL of solubilized 
membrane in 0.5% Triton-X, 105 µL of pelleted membrane and 30 µL of 5% Triton-X 
were added to 165 µL of lysis buffer.   
2.2.1.7 SDS-PAGE and Western blotting of membrane-associated proteins 
from human and rat RBCs 
The following protocol was used for Western blotting and visualization of 
proteins from both human and rat RBCs. The total protein concentration of membrane 
fractions prepared as described in Section 2.2.1.4 and Section 2.2.1.6 was determined by 
the Bradford method. SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
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electrophoresis) was used to separate proteins in isolated membrane fractions according 
to size. Following the addition of 10% w/v SDS, proteins were briefly heated to near 
boiling in the presence of the reducing agent, β-mercaptoethanol, to further denature the 
proteins by reducing disulfide linkages and to interrupt quaternary complexes. This is 
known as reducing SDS-PAGE, and was used in our investigation (Fig 3.1, Fig 3.3, Fig 
3.9, Fig 4.1, Fig 5.1, Fig 6.1). Non-reducing SDS-PAGE (no boiling and no β-
mercaptoethanol) was used for the investigation of effects of NEM on Prx2 
oligomerization state (Fig 3.8).  
Loading buffer (5x, 10% w/v SDS, 10 mM β-mercaptoethanol, 20% v/v glycerol, 
0.2 M Tris-HCl, pH 6.8, 0.05% bromophenol blue) was added to the samples. A 1-mm 
thick resolving gel (12%) and stacking gel (6%) were prepared and 30-35 µg total protein 
were loaded per lane. A Nu-Page Novex Transfer System (from Invitrogen) was 
assembled and running buffer 1x (3.03 g/L Tris base, 1 g/L SDS, and 14.4 g/L glycine) 
was used to separate the proteins at 150 V (Hoefer SX250 Power Supply). Transfer 
buffer (3.03 g/L Tris base, 14.4 g/L glycine and 20% methanol) was used to transfer the 
proteins from the gel to the PVDF membrane (100 mA, 2 h). After transfer, the PVDF 
membranes were immunoblotted with the appropriate antibodies as described in Section 
2.2. Membranes were blocked for 2 h with 5% milk in Tris-buffered saline (TBST; 137 
mM NaCl, 20 mM Tris, 0.1% Tween-20), incubated with the primary and secondary 
antibodies in 1% milk in TBST. Antibody incubations for 2 h at 25 ºC were performed 
except when probing with sheep polyclonal anti-human Gpx1 which was incubated 
overnight at 4 ºC for optimum signal detection. The primary antibodies recognize the 
human antigens (Section 2.2.2.3) but also cross-reacted with antigens in rat RBCs. 
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2.2.1.8 Densitometry of membrane-associated proteins from human and rat 
RBCs 
The proteins were visualized by chemiluminescence using AlphaImager densitometer 
(Alpha Innotech Corporation, USA) using Fluorchem FC2 software, Version 3.0. 
Densitometry, or image quantification, was performed for each protein antigen to 
establish the linear range of the chemiluminescence signal (152). Densitometry integrates 













Fig 2.3 Densitometry measurements. (А) Various amounts of a membrane protein detected by Western 
blotting using antibodies as described in Section 2.2.1.7. (B) Тhe densitometer passes a beam of light 
through the PVDF membrane and measures the absorbance of light by the sample bands such as those in 
Panel A. An intense band produces an intense absorbance peak because most light is absorbed whereas a 













































The instrument passes a beam of light through the PVDF membrane and measures 
the absorbance of light by the sample. If the band is intense, most of the light is absorbed 
(large peak in absorbance). If the band is weak, most of the light passes through and the 
densitometer displays a small absorbance peak (153). 
2.2.1.9 Coomassie staining of PVDF as loading control 
Staining with Coomassie dye of the entire PVDF membrane was used as loading 
control according to procedure of Welinder et al. (154). PVDF membranes were rinsed 
briefly with H2O after visualization by chemiluminescence and immersed in 0.1% 
Coomassie R-250 in methanol/H2O (1:1) for 1 min, and destained for 20 min in acetic 
acid/ethanol/H2O (1:5:4). The PVDF membranes were then washed briefly with H2O, air-
dried and scanned in a flatbed scanner (UMAX Powerlook III) at 600 dpi. The densities 
of all bands in each lane on the scanned image were summed using the AlphaImager 
densitometer. The background was established from the areas between the bands and 
subtracted from each band. 
2.2.1.10 Standard plot preparation 
The semi-quantitative Western blot, or immunoblot, allows quantitation of specific 
protein antigens by antibodies in biological samples after preparation of a standard plot 
for each protein (152). The unknown samples of interest are compared to the standard 
plot. After the membranes were isolated from RBCs, the total protein concentration was 
determined and equal amounts of total protein were loaded onto an SDS-PAGE to 
separate proteins according to molecular weight. Proteins were transferred (blotted) to a 
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PVDF membrane for subsequent antibody detection of antigen(s) found on the target 
proteins. 
It is critical to avoid oversaturation of the ECL signal (152) as this would prevent 
accurate determination of the relative quantities of membrane-associated. The 
concentrations at which signal saturation occurs varies for each protein antigen and 
antibody.  Therefore, the linear range of total protein loaded on a gel must be determined 
for each analyte. For example, the total protein per lane was 3-100 µg for CuZnSOD and 
1–100 µg for catalase, Prx2 and Gpx1. To correct for errors due to inhomogeneities in 
blot transfer and to normalize for gel loading, the Welinder method (Section 2.2.1.9) was 
used with modifications for loading control (154). 
2.2.2 Localization of proteins in fixed human RBCs by confocal microscopy  
2.2.2.1 Preparation of human RBCs 
Whole human blood collected as described in Section 2.2.2.1, was transferred to 
2.0-mL Eppendorf tubes and centrifuged at 1000 xg for 6 min at room temperature. After 
removal of the upper layer (plasma and buffy coat) by pipette, the RBC pellet was 
washed three times in G-PBS and resuspended in this buffer at 10% hematocrit (Ht) 
where Ht is the percent by volume of RBCs in whole blood. Cells were examined using a 
light microscope with a 40x objective (Model M11-45659 Wild Heerbrugg, Switzerland) 




2.2.2.2 Fixing and permeabilization of human RBCs  
Cell fixation preserves cell structures and protects against subsequent treatments 
such as rinsing, permeabilizing and staining. Fixation is a necessary step in 
immunohistochemistry before visualization (155). Acrolein (Fig 2.4) is an aldehyde used 
for fixation because it reacts with  protein side chains.  including Cys, His, and Lys as 
shown in Scheme 2.1 (156). Crosslinking may interfere with antibody access to epitopes 
on target proteins. Furthermore, aggressive fixation has been shown to alter spatial 
relationships of macromolecules (157). Thus, to characterize the localization of 
antioxidant proteins in RBCs under physiologically relevant conditions, we used a 
method developed for RBCs by Low and coworkers (157) to rapidly fix freshly isolated 
human RBCs. To crosslink proteins side chains, a 50-μL aliquot of cells at 10% Ht was 
centrifuged at 1000 xg (3300 rpm, MicroMax RF Centrifuge, Thermo IEC) for 5 min at 
room temperature. The RBC pellet was resuspended in 1 mL of 0.5% acrolein in PBS, 
gently mixed for 5 min at room temperature, centrifuged at 650 xg (2145 rpm) for 1 min 
and the supernatant was removed. The RBC pellet was rinsed 3x with rinsing buffer (PBS 
containing 0.1 M glycine) to remove excess acrolein, which reacts with the free amino 
group of glycine. Cells were then permeabilized in 1 mL rinsing buffer plus 0.1% Triton-
X for 5 min, rinsed three times in rinsing buffer and further incubated in rinsing buffer at 



















  Scheme 2.1 Reaction of acrolein with proteins (adapted from ref (158)) 
 
2.2.2.3 Staining of human RBCs for CuZnSOD, catalase, Gpx1 and Prx2 
Fixed, permeabilized RBCs were next processed for immunofluorescence 
microscopy. After incubation in rinsing buffer for 30 min, the RBCs were pelleted by 
centrifugation at 650 xg for 1 min. To prevent nonspecific antibody binding, the pellet 
was resuspended (5% Ht) and incubated in blocking buffer (PBS containing 0.05 mM 
glycine, 0.2% fish skin gelatin, and 0.05% sodium azide) for 60 min. Staining of the 
fixed, permeabilized RBCs at 5% Ht was performed by incubating with the primary 
antibody at 1% dilution in blocking buffer overnight at 4 ºC with gentle shaking. The 
RBCs were rinsed 3x in rinsing buffer, and incubated with secondary antibodies in 
blocking buffer with gentle shaking at room temperature for 2-3 h. After labelling, the 
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aliquot of labelled RBCs was added to a glass slide coated with 10% polylysine and 
mounted using Aqua-Mount (Lerner Laboratories, USA). 
2.2.2.4 Confocal microscopy of fixed human RBCs 
Stained, fixed RBCs were visualized using the 63X/1.32 optical objective on a Leica 
TCS SPII laser confocal microscope at The Centre for Microscopy at Concordia 
(CMAC). The dyes, Cy2 and FITC, in the stained RBCs were excited with the 488/514 
nm blue Argon laser. An emission filter was selected to ensure that the fluorescence from 
the samples did not include any laser light (Fig 2.5). The diameter of the detection 
pinhole was 1 Airy unit, which produced the best signal-to-noise ratio. The laser light 
































Fig 2.5 Excitation (blue) and emission (red) spectra of FITC and Cy2 dyes. In each panel, the 
excitation wavelength is marked by a dashed blue line, and the range of emission wavelengths detected by 
the confocal microscope is bracketed by the dashed pink lines. The excitation wavelength and the detected 
emission range were (A) 488 nm and 500-530 nm for FITC, and (B) 492 nm and 510-530 nm for Cy2. 














 Chapter 3: Characterizing controls for immunoblotting, 
immunofluorescence and hemolysis 
 
3.1 Standard plot preparation of the detection of CuZnSOD, catalase, Prx2 and 
Gpx1 
Standard plot preparation is a necessary step to determine the relative amounts of 
the proteins at the RBC membrane by semi-quantitative Western blotting. Standard plots 
were prepared for CuZnSOD, catalase, Prx2 and Gpx1 as described in Section 2.2.1.10. 
Samples containing different amounts of total protein from isolated membranes were 
tested (Fig 3.1). Quantification was performed in the linear range of the plot, avoiding 
concentrations at signal saturation where the curve levels off (Fig 3.2) Also, four 
standards from the linear region of a standard curve were chosen as controls and loaded 
on all subsequent gels (Fig 3.3).  
Images were visualized using an enhanced luminol-based chemiluminescent 
substrate (ECL, Supersignal West Pico Chemiluminescent Substrate Kit, cat #34080, 
Thermo Scientific) for detection of horseradish peroxidase (HRP) activity from 
secondary antibodies on immunoblots (152). The ECL Western blotting detects 
picograms (pg) of antigen. The ECL kit contains Stable Peroxide Solution and the 
Luminol/Enhancer Solution and equal volumes of each were mixed. Following transfer, 
the proteins were visualized as described in Section 2.2.1.8 by submerging the PVDF 





of membrane). Saturation of images was minimized by avoiding overloading 
the SDS-PAGE gel and by using recommended antibody concentrations.  
 
3.2 Linear range for CuZnSOD, Prx2, catalase and Gpx1 analysis by Western 
blotting 
The standard plot for CuZnSOD is shown in Fig 3.2A based on the corresponding 
Western blot in Fig 3.1A. Linearity is maintained up to ~75 μg total protein for 
CuZnSOD and it was determined that 35 μg total protein is the optimum amount to load 
on each gel for CuZnSOD. This amount allows increases or decreases in the 
chemiluminescence signal to be detected if the amount of membrane-associated 
CuZnSOD is lower or higher than expected. 
The standard plots for catalase, Prx2 and Gpx1 are shown in Fig 3.2B, C, D based 
on corresponding Western blots in Fig 3.1B, C, D. The plots shown in Fig 3.2 are 
biphasic, with two linear regions (shown by the red and blue lines in Fig 3.2). Ideally, the 
first more steep linear region should be used for standard curve preparation (red line, Fig 
3.2) with a signal linear to ~12.5 μg total protein for catalase, Prx2 and Gpx1. 
Analogously to the standard plot for CuZnSOD, ideally ~6 μg, should be loaded per lane 
for catalase, Prx2 and Gpx1. However, the chemiluminescence signal would be rather 
low at these concentrations (Fig 3.1B, C, D) and should there be more than a 2-fold 
decrease in the signal upon treatment, no band would be observed. This was 
circumvented by choosing the second linear region (with smaller slope) at higher total 
protein concentrations seen in Fig 3.2B, C, D enclosed by the dotted lines. This was 
previously demonstrated as a good compromise between signal strength and linearity 
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(152).  It was determined that 30 μg total protein was the optimum amount to be loaded 
on each gel for each condition tested for catalase, Prx2 and Gpx1. The linear regions and 









Fig 3.1 Determination of the linear region in Western blots of CuZnSOD, catalase, Prx2 and Gpx1 in 
human RBC membranes. RBCs were washed and lysed in 40 mM hypotonic sodium phosphate buffer 
(1:15 dilution) containing 0.1 mM PMSF, pH 7.4 at room temperature as described in Section 2.2.1.1 and 
2.2.1.4. Prx2 sample was treated with 100 mM NEM for 15 min. Hemolysates were immediately 
centrifuged at 30,000 xg (14,800 rpm) on Beckman J2-HS centrifuge at 4 ºC and membrane fractions were 
isolated and resuspended in 100 µL of hemolysis buffer (40 mM sodium phosphate, pH 7.4) containing 0.1 
mM PMSF. Proteins from the isolated membranes were separated by a reducing SDS-PAGE and Western 
blotted as described in Section 2.2.1.7. (A) CuZnSOD in isolated RBC membranes were blotted and probed 
with rabbit polyclonal anti-CuZnSOD (Stressgen SOD-100), 1:1000 dilution, 1.5 h. (B) Catalase in isolated 
RBC membranes blotted and probed with sheep polyclonal anti-catalase (Abcam, ab8954), 1:1000 dilution, 
1.5 h. (C) Prx2 in isolated RBC membranes blotted and probed with rabbit polyclonal anti-Prx2 (Abcam, 
ab15572), 1:10 000 dilution, 1.5 h. (D) Gpx1 in isolated RBC membranes blotted and probed with sheep 
polyclonal anti-Gpx1 (Abcam, ab8850), 1:7000 dilution, overnight incubation. The secondary antibody 
used for catalase and Gpx1 was donkey anti-sheep (HRP-conjugated, Abcam, ab6900), at a 1:5000 dilution, 
1.5 h. The secondary antibody used for CuZnSOD and Prx2 was goat anti-rabbit (HRP-conjugated, Biorad, 
1706615), also at a 1:5000 dilution. The PVDF membranes were incubated with the antibodies for 1.5 h. 
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From the ten point-standard plots, four total protein concentrations were selected 
to be loaded on each subsequent Western blot (Table 3.2). Representative Western blots 
of selected controls are shown in Fig 3.3 and good linearity is observed between the total 

















Fig 3.2 Standard plots of CuZnSOD, catalase, Prx2 and Gpx1 in isolated membranes from human 
RBCs. (A) CuZnSOD (B) Catalase (C) Prx2 (D) Gpx1. Densitometry was performed on the Western 
blots shown in Fig 3.1 by using FluorChem FC2 imaging software and the background was subtracted. 
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Table 3.1:  Summary of linear regions and optimum protein loaded for CuZnSOD, catalase, Prx2 and Gpx1 
as determined from standard plots in Fig 3.2 and detected by Western blotting. 
Antioxidant protein a) Linear region b) Optimum total protein per gel lane 
CuZnSOD 3 - 75 µg 35 µg 
catalase 12 - 60 µg 30 µg 
Prx2 NEM 12 - 60 µg 30 µg 
Gpx1 12 - 60 µg 30 µg 
 
a) Determined from standard plots in Fig 3.2 
b) Determined for subsequent Western blots 
 
Table 3.2:  Total protein controls for Western blotting  
Antioxidant protein a) Four-point standard plot 
CuZnSOD 25, 37.5, 50, 75 μg 
catalase 12.5, 25, 37.5, 60 μg 
Prx2 NEM 10, 25, 40, 60 μg 
Gpx1 10, 25, 40, 60 μg 
 
a) These total protein concentrations were selected as controls for representative Western blots shown in 









Fig 3.3 Four CuZnSOD, catalase, Prx2 and Gpx1 controls to be loaded on each gel for Western 
blotting. The signal strength varies linearly with each protein concentration loaded. The signal strength 









µg 25 37.5 50 75 
 
µg 12.5 25 37.5 60 
 
 Prx2 NEM  Gpx1 
µg 10 25 40 60 
 




3.3 Sum of Coomassie bands as a loading control in Western blot analysis 
Western blotting is a powerful and widely used technique for specifically 
measuring the content of single proteins in complex biological mixtures. Two factors that 
need to be controlled to ensure reliable comparisons of protein amounts in different 
samples are the total amount of protein loaded to each well in the electrophoretic 
separation and the efficiency of transfer in the blotting procedure. To address these 
possible sources of error, antibodies directed against housekeeping proteins are often 
used as loading controls, assuming these housekeeping proteins are constantly expressed. 
However, several problems are associated with this procedure. For example, when low 











Fig 3.4 Plot of summed band intensities vs total protein per lane.  A representative plot shown for 
RBC membrane proteins, R
2
=0.9842 (A) After visualization by chemiluminescence, the PVDF 
membrane was stained with Coomassie, air-dried and scanned as described in Section 2.2.1.9. (B) The sum 
of the intensities of all the bands enclosed by the rectangle was recorded by densitometry as described in 
Section 2.2.1.8. Note that the Hb band intensity was excluded from the sum because of its irreproducible 
size and shape.   
 






























control (159). Also, there might be overlap in molecular weight between the sample and 
control. 
Thus, to monitor protein loading and blotting efficiency, we used the Welinder 
method as a loading control (154) as described in Section 2.2.1.9. This method involves 
Coomassie staining of the PVDF membrane after the immunodetection step and provides 
superior linearity over antibody detection of housekeeping proteins. A representative plot 
of total protein per well (Fig 3.4A) vs relative intensity (Alpha Imager) is shown in Fig 
3.4B. This method assesses the transfer efficiency of the entire lane, except Hb (because 
of its irreproducible size and shape) as opposed to one specific region, and was used as a 
loading control for all the Western blots reported here. Coomassie staining of PVDF 
membranes is performed after protein visualization and does not interfere with the 
chemiluminescence signal. The method works for PVDF but not for nitrocellulose 
membranes because the latter react with the Coomassie stain producing a dense 
background. PVDF membranes were scanned in a flatbed scanner (UMAX Powerlook 
III) at 600 dpi and the sum of the densities of all bands found in a lane was determined by 
densitometry. 
 
3.4 Confocal controls for CDB3 and Hb localization in human RBCs 
To characterize the localization of antioxidant proteins in RBCs under 
physiologically relevant conditions, we used a method developed by Low and coworkers 
in 2004 (157). Isolated fresh human RBCs were rapidly fixed as described in Section 
2.2.2.2 and the localization of antioxidant enzymes in the intact cells was then examined 
by confocal microscopy as described in Sections 2.2.2.3 and 2.2.2.4. The working 
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conditions for cell fixing and staining were established by examining the localization of 












Fig 3.5 Confocal immunofluorescence and corresponding bright field images of Hb and CDB3 in 
fixed intact human RBCs. The bright filed images are shown in the upper panels and the corresponding 
immunofluorescence images in the lower panels. Hb was stained by sheep polyclonal anti-human Hb and 
FITC donkey anti-sheep IgG. CDB3 was stained by mouse monoclonal anti-human CDB3 and Cy2 donkey 
anti-mouse IgG. Filter settings were as follows: excitation 488 nm; emission 500-530 nm. The RBC pellet 
was fixed and stained as described in Section 2.2.2.2 and 2.2.2.3. Cells were exposed to air for <5 min, and 
fixed within 2 h of drawing blood. 
 
Band-3 is an important structural component of the RBC membrane and each cell 
contains approximately 10
6
 copies of Band-3 (160). Hb is the main protein in the RBC 
cytosol, being present at 5 mM or ~270,000,000 copies. Invariably, as expected, staining 
for CDB3 revealed that the protein was concentrated at the membrane and Hb staining 








monoclonal anti-CDB3 antibody used in these studies specifically recognized an epitope 
within residues 1-136 of CDB3 (161). Hence, the membrane pattern of CDB3 staining in 
intact RBCs (Fig 3.5) confirmed that its antibody had access to the cytoplasmic side of 
the membrane after cell fixing and permeabilizing. CDB3, which comprises the first 403 
amino acid residues of Band-3 (162), binds peripheral proteins and might play a role in 
the localization CuZnSOD, catalase, Prx2 and Gpx1. Also, the Hb distribution (Fig 3.5) 
demonstrated that the highly dense macromolecular network of crosslinked Hb expected 
after chemical fixation does not restrict access of anti-Hb antibody to the cell interior. 
Therefore, the staining patterns observed for other target proteins should reflect their 
actual localization (157).   
 
3.5 Prx2 visualization in fixed human RBCs  
To establish the response of key RBC antioxidant enzymes, CuZnSOD, catalase, 
Prx2 and Gpx1, to various oxidative-stress conditions, their localization under 
physiological conditions was first characterized. Freshly drawn human RBCs were fixed 
and stained immediately after washing. Fresh human RBCs were previously stained for 
CuZnSOD, catalase, and Gpx1 in our laboratory (163). To obtain confocal data for Prx2, 
human RBCs were fixed and stained for Prx2 as described in Section 2.2.2.2 and 2.2.2.3. 
Using the filter settings given in the figure legend, the confocal images reveal that Prx2 is 
evenly distributed in the cytosol of untreated human RBCs (Fig 3.6). Notably, the 
staining pattern resembles the staining of Hb (Fig 3.5) in these cells, which were exposed 
to air for <5 min and fixed within 2 h of drawing blood. Its high concentration (~240 µM) 
in RBCs may mask membrane binding of Prx2 in control cells because we did not 
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attempt to distinguish cytosolic and membrane-bound Prx2 by confocal microscopy, 















Fig 3.6 Confocal immunofluorescence and corresponding bright field images of Prx2 in fixed intact 
human RBCs. The bright filed images are shown in the upper panels and the corresponding 
immunofluorescence images in the lower panels. Prx2 stained by rabbit anti-human Prx2 and Cy2 
conjugated donkey anti-rabbit IgG. Filter settings for Cy2 were as follows: excitation 488 nm; emission 
500-530 nm, 100x objective, Leica TCS SPII. The RBC pellet was fixed and stained as described in 
Sections 2.2.2.2 and 2.2.2.3. Cells were exposed to air for <5 min, and fixed within 2 h of drawing blood. 
 
3.6 Determination of most appropriate hemolysis method 
The RBC plasma membrane is a complex structure consisting of ~50% protein, 
~40% lipid and ~10% carbohydrate (11). Gentle hemolysis of RBCs is necessary to 






Ghosts, or post-hemolytic residues of RBCs, are widely used in studies of the 
composition, structure and function of RBC membranes. They are devoid of cellular 
structure and consist primarily of the plasma membrane.  
Ghosts are prepared by the addition of hypertonic or hypotonic buffers to RBCs 
which either crenate (shrink) or lyse cells (164). Hypotonic hemolysis is most often used 
because such ghosts have membranes with a composition similar or identical to those of 
intact RBCs (164). Osmotic pressure difference between the RBC cytosol and the 
surrounding medium induces mechanical stress because water flows into the cells. At a 
certain critical level of membrane tension or stretch during swelling, holes form in the 
membrane and some Hb molecules escape after which the osmotic pressure difference 
between the cell cytoplasm and the surroundings vanishes and the holes close (164). The 
properties of the ghosts depend on the conditions at the instant of disruption of the 
plasma membrane (165). Two types of hypotonic ghosts can be prepared from RBCs: 
white ghosts and resealed ghosts. White ghosts are essentially devoid of Hb with no 
significant loss of membrane material. White ghosts are used for quantitative 
determination of various membrane structures, for studying RBC membrane properties, 
and investigation of enzyme activities at the membrane.  
Resealed ghosts are generally used to study how variations in cell interior and 
extracellular medium might be involved in transport processes. The contents inside the 





it has been shown that cations affect membrane binding of some RBC proteins, resealed 
ghosts are not suitable for our investigation on the localization of antioxidant proteins. 
For example, when human RBCs are exposed to Ca
2+
, catalase increases its membrane 
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binding (166). Thus, we used a modified protocol for white ghost preparation to 
investigate membrane association of the antioxidant proteins CuZnSOD, catalase, Gpx1 
and Prx2. 
Several methods for the hemolysis of human RBCs to obtain white ghosts have 
been described in the literature. Hillier & Hoffman first used stepwise hypotonic 
hemolysis in solutions of increasingly lower salt concentrations (167). Weed et al. 
showed that repeated hemolysis at decreasing salt concentrations is not necessary for 
obtaining Hb-free white ghosts (168). The most widespread hypotonic hemolysis method, 
developed by Dodge et al., is a single-step hemolysis for preparation of Hb-free white 
ghosts (169). This protocol represents a compromise between two conflicting 
requirements: the removal of the cytosolic contents while retaining the native 
organization of the plasma membrane without significant loss of membrane material. 
Dodge et al. studied the effects of phosphate concentration and pH of the 
hemolysis buffer on Hb content and reorganization of the plasma membrane during white 
ghost preparation (169). The experiments were carried out at 4 ºC because the rate of 
dissolution of membrane proteins in aqueous media is strongly dependent on the 
temperature and is greatly reduced at 4 ºC. Dodge et al. reported that incubation of RBCs 
in 10 mM phosphate (pH 7.4) for 30 min removed most Hb from membrane when the 
membrane was subsequently washed with the same buffer. Hemolysis with 40 mM 
phosphate (pH 7.4) for 30 min left most Hb membrane-bound. Photomicrographs 
revealed that their white ghosts were approximately equal in diameter and similar in 
structure to intact RBCs with minimal reorganization of the membrane. The total amount 
and composition of lipids in these Hb-free ghosts were essentially comparable to those 
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found in intact RBCs (169). Nevertheless, in this work no biochemical analysis of 
membrane composition was performed and the authors relied on microscopy methods to 
analyze protein and lipid composition of the membrane. 
Further published studies on the behaviour of membrane proteins after human 
RBC hemolysis lead us to conclude that hemolysis in 40 mM phosphate might be a more 
desirable condition for our investigation. Duchon et al. (148) reported that hemolysis in 
15-40 mM phosphate yields intact white ghosts but with varying amounts of Hb at the 
membrane. They studied the recovery of enzyme activities after hemolysis at various 
phosphate concentrations and divided enzymes into two classes. The first class were 
loosely-bound and included the glycolytic enzymes triose-phosphate isomerase, lactate 
dehydrogenase, and also Gpx1. These proteins were lost from the membrane after 
exposure of white ghosts to low phosphate concentrations (10 mM) but were retained at 
30 to 40 mM phosphate. Proteins in the second class were firmly-bound, including 
GAPDH and aldolase, which remained membrane-associated after hemolysis in 10 mM 
phosphate.  Bramley et al. (170) observed less loss of membrane-associated proteins at 40 
mM phosphate than at 15 mM phosphate. 
From the above reports, it seems that human RBC hemolysis conditions critically 
determine the Hb content of ghosts and the preservation of native membrane structure 
with minimal protein loss. Thus, we further tested several hemolysis methods to optimize 
our hemolysis protocol. We lysed fresh human RBCs with 10 mM or 40 mM phosphate 
with or without N-ethylmaleimide (NEM) over 15 min, pH 7.4 at 4 ºC to establish the 
effect on Hb content and antioxidant enzyme membrane localization. NEM is a thiol-
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specific alkylating agent that prevents disulfide formation, including Prx2 dimerization 
which has been previously shown to occur as an artefact during hemolysis (117).  
We investigated how phosphate concentration of the hemolysis buffer affects Hb 
membrane association by UV-Vis spectroscopy (Fig 3.7). Our spectroscopy data 
demonstrate that 40 mM phosphate in the lysis buffer results in more membrane-
associated Hb than lysis with 10 mM phosphate (Fig 3.7) as observed by Dodge et al. 
(169). NEM had no effect on membrane-associated Hb but 30 min incubation following 
hemolysis in 10 mM phosphate decreased the association of Hb with the membrane (Fig 
3.7). This indicates that 30 min incubation decreased Hb at the membrane and incubation 
periods should be minimized to avoid loss of other proteins that might interact with 
membrane-associated Hb.  
Our investigation was further extended to investigate how hemolysis buffer 
osmolarity affects not only Hb-membrane association but also association of RBC 
antioxidant proteins with the membrane. We used non-reducing SDS-PAGE to observe 
the effect of NEM on Prx2 dimerization (Fig 3.8). SDS disrupts protein secondary, 
tertiary and quaternary structure and a reducing agent such as β-mercaptoethanol reduces 
any intramolecular bonds and cleaves any bonds formed during disulfide crosslinking. 
The only protein examined in the current work by non-reducing SDS-PAGE is Prx2 in 
Fig 3.8 since it has previously been reported to oligomerize in human RBCs (171). In Fig 
3.8, lanes 1-6, Prx2 is mainly associated with the membrane as dimer in the absence of 
NEM, as previously reported by Low et al. (117). Since transfer of proteins from a non-
reducing gel to a PVDF membrane is challenging and the amounts transferred differ 
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Fig 3.7 Hb content of membrane fractions from human RBCs varies with the phosphate 
concentration in the hemolysis buffer but not after NEM addition (n=3). Isolated membranes from 
human RBCs diluted in water to 0.138 μg/µL total protein, pH 7.4. The supernatant was transferred to a 




 (per heme). Absorbances 
were read immediately after sample preparations on an Agilent UV-Vis spectrophotometer at 10 mM 
(black and green solid lines) or 40 mM phosphate (coarse and fine dashed lines). An incubation time of 30 
min was in 10 mM phosphate concentration also was examined (solid green line).  NEM (100 mM) 
addition to the 40 mM phosphate hemolysis buffer (coarse dashed line) had no effect on the Hb content. 
Note that the absorbance for Hb in 40 mM phosphate and 40 mM phosphate/100 mM NEM overlap. Hb is 




regarding the relative amounts of dimer vs monomer in lanes 1-6. However, upon NEM 
addition to the hemolysis buffer, we conclude that at the membrane Prx2 is mainly 
monomeric (lanes 5, 6 vs lanes 7, 8) as previously reported (117). The faint band around 
10 M (no incub) 
1  M (30 min incub) 
4  M (no incub) 






25 kD might be an overoxidized (-SO2H or -SO3H) form of the Prx2 monomer which 
would explain its altered migration. Phosphorylated proteins have also been detected as 
slower migrating species by electrophoresis and Western blotting so the faint band at 25 
kD could be also the phosphorylated Prx2 monomer (172). A band at 25 kD has been 












Fig 3.8 Western blot of Prx2 from a non-reducing SDS- PAGE (no β-mercaptoethanol) of membrane 
fractions of human RBCs lysed in 10 mM phosphate ± 30 min incubation or 40 mM phosphate ± 100 
mM NEM. Human RBCs were collected and washed as described in Section 2.2.1.1. Membranes were 
isolated after hemolysis in 10 mM or 40 mM phosphate buffer ± NEM as described in Section 2.2.1.4. A 
non-reducing SDS-PAGE (no β-mercaptoethanol) and Western blotting of the isolated membranes was 
performed as described in Section 2.2.1.7. Either 10 µg or 25 μg of total protein per lane was loaded per 
lane as shown in table above and lanes 7, 8 contain Prx2 that was NEM treated.  
 
The concentration of phosphate in the hypotonic buffer influenced the amounts 
CuZnSOD, catalase and Prx2 (Fig 3.9) detected in isolated membrane fractions from 
human RBCs by reducing SDS-PAGE and Western blotting performed as described in 
phosphate (mM) 10 10 40 40 
NEM (mM) - - - 100 
incubation time (min) - 30 - - 
total protein per lane (μg) 10 25 10 25 10 25 10 25 
 




dimer (~37 kD) 
                       ~25 kD 
monomer (~21 kD) 
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Section 2.2.1.7. The relative intensity of each band is shown before and after correction 
for loading as described in Section 3.3. CuZnSOD at the membrane increased with 40 
mM phosphate in hemolysis buffer whereas less CuZnSOD was retained at the membrane 
when hemolysis was performed in 10 mM phosphate (Fig 3.9A). The phosphate 
concentration of hemolysis buffer had minimal effect on catalase localization (Fig 3.9B). 
However, the 4 µg bands gave a weak signal, which as revealed by the corrected relative 
intensities for each set of conditions (Fig 3.9B). Notably, Prx2 is sensitive to both 
incubation time in the lysis buffer and to NEM addition since its localization at the 
membrane increased after 30 min incubation in 10 mM phosphate but decreased after 
NEM treatment in 40 mM phosphate (Fig 3.9C). These results suggest that Prx2 forms a 
time-dependent disulfide bridge with a membrane protein, which is prevented when NEM 
is present in the hemolysis buffer.  
As discussed above, hemolysis in 40 mM phosphate (pH 7.4) keeps Hb at the 
membrane (Fig 3.7). Since 155 mM phosphate in hemolysis buffer is isotonic to the 
RBCs, using 40 mM phosphate (pH 7.4) is more physiologically relevant than using 10 
mM phosphate. Therefore, 40 mM phosphate was chosen for human RBC hemolysis 
throughout this work. Since 30 min incubation at 4 ºC seems to affect levels of 
membrane-associated Hb, such incubation was avoided in the present work. To prevent 
Prx2 dimerization during sample processing, 100 mM NEM was added to the hemolysis 
buffer of fractions to be probed for Prx2. Prx2 and catalase have been shown to interact 
with Hb in human RBC membranes (171) and washing away Hb from the membrane 
might lead to loss of crucial information pertaining to the localization of these antioxidant 
enzymes. Also, to minimize Hb removal from the membrane, no washing of ghosts was 
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For rat RBC hemolysis, 10 mM phosphate (pH 7.4, 4 ºC) buffer was used 
followed by immediate centrifugation according to the Dodge method (169). The Dodge 
method is commonly used for rat RBC hemolysis (173) and was also used in our work 
before the realization that phosphate concentration in the hemolysis buffer might have an 
effect on membrane-associated proteins. Interestingly, a subsequent search of the 
(C) Prx2 Fig 3.9 Effect of hemolysis method on 
CuZnSOD, catalase, and Prx2 membrane 
localization. RBCs were lysed with 10 mM 
phosphate ±30min incubation or 40 mM 
phosphate ±100 mM NEM. Semi-quantitative 
Western blots (n=1) for (A) CuZnSOD, (B) 
catalase, (C) Prx2 are shown. Proteins were 
separated by a reducing SDS-PAGE from 
membrane fractions isolated from human 
RBCs. The intensity of each band in the 
Western blots was recorded by densitometry as 
described in Section 2.2.1.8 and plotted after 
background subtraction. Relative intensities of 
bands are shown before and after correction for 
loading (Section 2.2.1.9). Gpx1 data are not 
available due to poor antibody binding. See 
appendix 3.1 for raw data of WB band intensity 




























































literature revealed that rat and human Hb have different properties. Rat Hb is found in a 
quazi-crystalline form inside rat RBCs and is more hydrophobic than human Hb, which is 
water soluble (174). Rat Hb has been shown to precipitate at pH 6.0 – 8.0 (175). 
Hydrophobicity might have an effect on Hb interaction with the RBC membrane. Also, 
species variability of transport ATP-ases among RBCs isolated from various mammals 















 Appendix 3.1 
Observed intensities for Fig 3.9. Effect of hemolysis method on (A) CuZnSOD, (B) 
catalase, and (C) Prx2 membrane localization in RBCs. Densitometry was performed 
on the Western blots shown in the figure and visualized on AlphaImager densitometer 
using FluorChem FC2 software and the background was subtracted. Western blots were 
visualized by chemiluminescence by ECL. The observed density readings of the WB 





















10 mM Pi 20 610.73 27.34 22.34 
10 mM Pi 50 1731.61 65.4 26.48 
10 mM  Pi/ 30 min incubation 20 541 25.46 21.25 
10 mM Pi/ 30 min incubation 50 1382.18 44.79 30.86 
40 mM  Pi 20 990.79 17.34 57.14 
40 mM Pi 50 2748.01 47.69 57.62 
40 mM Pi + 100 mM NEM 20 982.55 17.01 57.76 
40 mM Pi + 100 mM NEM 50 2650.96 51.91 51.07 












10 mM Pi 4 101.65 7.85 12.95 
10 mM Pi 10 581.54 17.36 33.50 
10 mM  Pi/ 30 min incubation 4 29.6 6.45 4.59 
10 mM Pi/ 30 min incubation 10 583.28 18.54 31.46 
40 mM  Pi 4 15.74 10.34 1.52 
40 mM Pi 10 463.55 18.5 25.06 
40 mM Pi + 100 mM NEM 4 10.63 5.68 1.87 
40 mM Pi + 100 mM NEM 10 354.51 14.89 23.81 
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10 mM Pi 10 529.39 15.43 34.31 
10 mM Pi 25 987.26 29.36 33.63 
10 mM  Pi/ 30 min incubation 10 868.69 16.52 52.58 
10 mM Pi/ 30 min incubation 25 2015.75 32.48 62.06 
40 mM  Pi 10 1246.56 16.54 75.37 
40 mM Pi 25 2106.83 29.67 71.01 
40 mM Pi + 100 mM NEM 10 396.51 15.31 25.90 




 Appendix 3.2 
 
Observed intensities for Fig 3.2. Standard plots of (A) CuZnSOD, (B) catalase, (C) 
Prx2, and (D) Gpx1 in isolated membranes from human RBCs. Densitometry was 
performed on the Western blots shown in Fig 3.1 and visualized on AlphaImager 
densitometer using FluorChem FC2 software and the background was subtracted. 
Western blots were visualized by chemiluminescence by ECL. The observed density 


















 100 6936.2 99.3 69.85 
 87.5 9196.33 95.25 96.55 
 75 6614.24 77.89 84.92 
 62.5 5850.26 60.79 96.24 
 50 4559.08 43.65 104.45 
 35 3365.42 26.69 126.09 
 25 2039.77 10.17 200.57 
 12.5 677.45 2.91 232.80 
 6.25 376.98 0.06 6283.00 
 3.13 1.61 0.00 1610000.00 











 100 2623.65   
 75 2544.27 102.52 24.82 
 50 2141.74 73.03 29.33 
 37.5 1825.34 52.99 34.45 
 25 1466.79 42.99 34.12 
 12.5 1062.40 30.51 34.82 
 6.3 642.01 20.09 31.96 
 3.2 293.12 9.50 30.85 
 1.5 41.77 4.15 10.07 



















 100 1801.63 104.59 17.23 
 75 1600.44 87.59 18.27 
 50 1463.24 72.77 20.11 
 37.5 1252.76 63.24 19.81 
 25 1102.79 53.71 20.53 
 12.5 704.91 36.97 19.07 
 6.3 359.58 20.88 17.22 
 3.2 88.39 13.86 6.38 
 1.5 105.43 6.76 15.60 
 0.78 43.24 3.18 13.60 










 100 2575.23 102.59 25.10 
 75 2437.94 85.59 28.48 
 50 1682.8 63.77 26.39 
 37.5 1460.65 54.24 26.93 
 25 1172.78 45.7 25.66 
 12.5 803.25 34.21 23.48 
 6.3 363.25 20.89 17.39 
 3.2 125.64 1.63 77.08 
 1.5 51.05 10.98 4.65 




 Chapter 4: Effects of prolonged air exposure on membrane 
localization of CuZnSOD, catalase, Prx2 and Gpx1 in human 
RBCs 
4.1 Introduction 
Our interest in the effects of prolonged air exposure on RBC antioxidant enzymes 
was triggered by our observation by confocal microscopy that CuZnSOD concentrated at 
the RBC biconcave surface following 60 min air exposure (163). This surface is 
presumably the site of highly efficient gas transport in RBCs because the shorter distance 
between the two biconcave surfaces in the RBC might allow for more interactions 
between cytoplasmic proteins and Band-3. Also, there have been several reports of the 
effects of O2 on RBC enzymes and properties. For example, prolonged exposure of 
humans to hyperbaric oxygen has been shown to decrease CuZnSOD and catalase 
activities in their RBCs, while Gpx1 activity was unaffected (176). Hyperbaric oxygen 
resulted in increased activity of lung CuZnSOD but decreased activity of lung catalase 
and Gpx1 (177). It was also shown that hyper-oxygenation leads to increased ROS 
formation in blood that causes cellular damage with lipid, protein and DNA oxidation 
(178). Notably, blood banks store blood for days to weeks in air-permeable bags, which 
causes RBC oxidation and irreversible changes in RBC proteins (77), collectively termed 
storage lesions.  
Oxygen not only is transported by RBCs to meet the metabolic requirements of 
tissues, but it also determines the mechanical (179) and membrane properties of RBCs 
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(180). Oxygenation regulates binding of Hb and glycolytic enzymes to the RBC 
membrane and it was suggested that Hb may act as a transducer regulating cellular 
function in an O2-dependent manner through its interaction with CDB3 (181). MetHb and 
deoxyHb can bind to CDB3, but not oxyHb, and this differential binding plays a role in 
the RBCs response to O2 levels (179, 182). Stored RBCs accumulate ROS and surface-
associated hemichromes, a partially denatured form of oxidized Hb (78). Interestingly, 
hemichromes have higher affinity for CDB3 than deoxyHb (37). 
To investigate how hyper-oxygenation, a form of oxidative stress (178), affects 
localization of antioxidant enzymes at CDB3, prolonged air exposure was used as a 
method of hyper-oxygenation. In the lungs, RBCs are exposed to O2 for only a few 
seconds so exposing them to ambient air for 30 or 60 min should mimic hyperbaric 
conditions with possible increased hemichrome formation. 
 
4.2 Results 
Western blots of CuZnSOD, catalase, Gpx1 and Prx2 in membranes isolated from 
human RBCs following air exposure for 30 min or 60 min are shown in Fig 4.1. The 
experimental procedure is described in Sections 2.2.1.2, 2.2.1.4 and 2.2.1.7. 
Densitometry was used to quantitate the intensity of the antibody-labelled bands from 
each Western blot as well as the intensity of the entire lane of the Coomassie-stained 
PVDF membranes (loading control) as shown in Fig 3.4. Once these values were 
determined, the intensity of the antibody band was divided by the intensity of the loading 
control yielding a corrected intensity in arbitrary units. These values were then 
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normalized by assigning the 0 min sample (control) value of 1, such that the fold-change 

















Fig 4.1 Western blots of CuZnSOD, catalase, Prx2 and Gpx1 in membrane fractions isolated from 
human RBC following air exposure for 0 min (control), 30 min and 60 min (n=3 individual donors). 
(A) CuZnSOD (B) Catalase (C) Prx2 (D) Gpx1. Washed RBCs (3x10
8
 cells/mL) were exposed to air at 37 
ºC for 0 min, 30 min and 60 min by gently stirring (Sections 2.2.1.1 and 2.2.1.2) and hypotonic hemolysis 
in 40 mM sodium phosphate buffer, pH 7.4 (Section 2.2.1.4). 15 min incubations with 100 mM NEM for 
Prx2 samples were performed prior to hemolysis. Proteins were separated by a reducing SDS-PAGE [35 µg 
total protein for CuZnSOD, 30 µg total protein for catalase, Gpx1 and Prx2 (Table 3.1)] and Western 
blotted (Section 2.2.1.7). Western blots were visualized by chemiluminescence as described in Section 
2.2.1.8 and analyzed data are shown in Fig 4.2. Lane 1: 0 min closed; Lane 2: 30 min closed; Lane 3: 60 
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Fig 4.2 Relative amounts of CuZnSOD, catalase, Prx2 and Gpx1 in membrane fractions isolated from 
human RBC following air exposure for 0 min, 30 min and 60 min (n=3 individual donors). (A) 
CuZnSOD (B) Catalase (C) Prx2 (D) Gpx1. Densitometry was used to quantitate the intensity of each band 
in Fig 4.1. Then, Coomassie staining of PVDF membranes was performed as a loading control (Section 
2.2.1.7) and the corrected chemiluminescence intensities were normalized to 0 min control. The normalized 
relative intensities are shown for each protein ± S.E.M. Raw data are presented in Appendix 4. The 
statistical significance (*) of differences between the control (0 min) and treated RBCs was determined by 
Student’s t-test (unpaired, 2–tailed), and p-values ≤ 0.05 were considered significant. The 2-tailed Student 
t-test is used when examining significant differences between control and treated RBCs without prior 
assumptions which group would be higher (or lower). An unpaired Student t-test is used when there is no 
need to control for a third confounding variable. 
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4.2.1. CuZnSOD localization after air exposure  
Fig 4.1A reveals that a fraction of CuZnSOD is membrane-associated in all 
samples. Fig 4.2A indicated that there is a progressive loss of membrane CuZnSOD over 
60 min incubation time (closed tubes). RBCs become more anaerobic in closed tubes and 
therefore levels of deoxyHb increase. DeoxyHb has high affinity for the RBC membrane 
(34) and may displace CuZnSOD from the membrane. Also, there was loss of CuZnSOD 
from the membrane on longer air exposure (open tubes). In highly aerobic RBCs, the 
oxyHb content is high and thus metHb formation increases. Hence, there is a possibility 
that metHb competes with CuZnSOD for the membrane in highly aerated cells.  
4.2.2. Catalase localization after air exposure  
A fraction of catalase is membrane-associated in all samples (Fig 4.1B). Since the 
levels do not decrease after 30 or 60 min incubation (closed tubes), it seems that 
membrane-associated catalase does not depend on the deoxyHb concentration in RBCs 
which is expected to be elevated in the closed tubes. Hence, it is possible that deoxyHb 
and catalase are not competing for the same binding site on CDB3. Sialic acid-modified 
catalase has been reported (183) and catalase has been shown to bind human RBC 
membranes reversibly via electrostatic interactions (184). Sialylation might be required to 
anchor catalase to the RBC membrane since sialic acid addition will modify its surface 
charge and thereby increase its electrostatic interaction with the membrane. 
It has been shown that RBC catalase activity decreases after RBCs are hyper-
oxygenated (176) so we expected to see changes in catalase localization after prolonged 
air exposure. Catalase significantly increases at the membrane after 30 min air exposure 
 72 
 
and this increase continues after 60 min air exposure (Fig 4.2B, open tubes). Prolonged 
air exposure generates more O2
●
¯ at the membrane, which is rapidly dismutated to H2O2 
by CuZnSOD. Thus, increased H2O2 generation at the membrane may trigger catalase to 
migrate to the RBC membrane to protect it. Alternatively, catalase recruitment at the 
membrane after prolonged air exposure may be triggered by phosphorylation of Tyr8, 
Tyr21 and Tyr46 of CDB3 (26, 185). Phosphotyrosine phosphatase PTP1B has been 
proposed as the main membrane-associated PTPase that dephosphorylates Band-3 (186). 
Increased oxidative stress in aerated RBCs (80) leads to increased CDB3 phosphorylation 
due to PTP1B inactivation on oxidation of its active-site Cys215 (187). Such increased 
CDB3 phosphorylation in aerated RBCs should cause a loss of membrane-associated 
catalase. However, catalase levels at the RBC membrane increased after air exposure (Fig 
4.2B) and we conclude that CDB3 phosphorylation does not regulate catalase membrane 
binding. Hemichrome formation might also act as a trigger for catalase to migrate to the 
RBC membrane. It was reported that catalase and Prx2 migrate together to the membrane 
of stored RBCs (171) and we speculate that Prx2 migrates to counteract the association of 
hemichromes with the membrane. Hemichrome formation is known to trigger Band-3 
clustering, which marks altered RBCs for removal (17). 
4.2.3. Prx2 localization after air exposure  
Prx2 was maintained in its monomeric form by the addition of NEM following air 
exposure. A fraction of Prx2 is membrane-associated in all samples (Fig 4.1C), which is 
also confirmed by the confocal image in Fig 3.6. There is no obvious increase in Prx2 at 
the membrane after incubation (closed tubes) and air exposure (open tubes). Prx2 is a 
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highly abundant RBC protein (14x10
6
 copies per RBC) (107) and is proposed to act as a 
chaperone for Hb (117), but the nature of its native oligomeric form inside the RBC is 
still a matter of considerable debate. It has been suggested that catalase and decameric 
Prx2 migrate to the RBC membrane in stored blood (171). The same group also reports 
dimers, trimers, pentamers, heptamers and decamers for cytosolic Prx2. Our experiment 
(Fig 4.1C) does not distinguish among various Prx2 oligomeric states at the RBC 
membrane. Moreover, we cannot distinguish how decameric Prx2 might bind to the 
membrane. If Prx2 binds via one subunit only, the other subunits might be lost in the 
processing of RBCs during isolation of membranes. Also, masking of the antigen during 
Prx2 oligomerization might limit antibody binding to Prx2. 
4.2.4. Gpx1 localization after air exposure  
Gpx1, an abundant RBC enzyme present at 4x10
5 
copies, is an efficient lipid 
peroxidase (188). No change in membrane-associated Gpx1 was observed with 
incubation time in closed tubes (Fig 4.2D) and some Gpx1 is membrane-associated in all 
samples (Fig 4.1D) to protect the RBC membrane. Gpx1 increases at the membrane after 
60 min air exposure (open tubes). What triggers Gpx1 recruitment to the membrane? 
Hyper-oxygenation has been associated with increased levels of lipid peroxidation (189), 
and oxidized lipids increase in volume (190). Thus, Gpx1 might be attracted to the 
changes in volume at the membrane. Gpx1 likely migrates specifically to areas rich in 




4.3 Discussion  
Еxposing RBCs to ambient air for 30 or 60 min alters the membrane localization of 
antioxidant enzymes (Fig 4.2). Our data demonstrate that CuZnSOD decreases at the 
RBC membrane after incubation for 30 and 60 min in closed tubes (Fig 4.2A). Also, we 
report that there is an overall decrease of CuZnSOD at the membrane after prolonged air 
exposure (Fig 4.2A, open tubes). Photomicrographs taken in our laboratory showed that 
60 min air exposure caused relocalization of CuZnSOD to the biconcave surface (Fig 
4.3G) as compared to control cells (Fig 4.3A) (163). A rapid change in CuZnSOD 
localization is not unexpected since RBCs need to respond promptly to stress, such as 
hyper-oxygenation. 
There are four Cys residues in each subunit of human CuZnSOD (Cys6, Cys57, 
Cys111, Cys146). Cys57 and Cys146 form an internal disulfide bond. Cys6 is buried and 
Cys111 is solvent exposed, near the dimer interface next to His110 and Asp109 (191). 
Because of its solvent exposure, it has been suggested that Cys modification of native 
CuZnSOD occurs exclusively at Cys111, which could be involved in a disulfide bond 
formation (191, 192). However, since all of the Cys residues are near the subunit 
interface and close to each other, any of the six residues in the homodimer could be 
involved in interactions with the RBC membrane. Decreased CuZnSOD activity in 
human RBCs following hyper-oxygenation was previously reported (176).  
Catalase significantly increases at the membrane after 30 min air exposure and the 
increase continues after 60 min air exposure (Fig 4.2B, open tubes). This finding is 
consistent with confocal results recorded previously in our laboratory since 















Fig 4.3 Confocal immunofluorescence and corresponding bright field images of CuZnSOD, catalase, 
and Gpx1 in fixed intact human RBCs – control (A, B, C) vs aerated (D, E, F, G, H, I), data  previously 
obtained in our laboratory (163). Control RBCs were exposed to air for <5 min, and fixed within 2 h of 
drawing blood. Aerated RBCs were processed within 3 h of drawing blood and RBCs at 10% Ht in G-PBS 
were exposed to room air for 1 h at ambient temperature. The bright field images for the aerated RBCs are 
shown in panels D, E, F and the corresponding immunofluorescence images in panels G, H, I. RBCs were 
then stained as outlined in Section 2.2.2. CuZnSOD stained by rabbit polyclonal anti-human CuZnSOD and 
Cy2 conjugated anti-rabbit IgG. Catalase stained by sheep polyclonal anti-human catalase and Alexa 
conjugated anti-sheep IgG. Gpx1 stained by sheep anti-human GPx-1 and Alexa 488 conjugated anti-sheep 
IgG. Filter settings for both Cy2 and Alexa 488 were as follows: excitation 488 nm; emission 500-530 nm.  
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exposure (Fig 4.3H) as compared to control in Fig 4.3B (163). It has been reported that 
catalase competes with Hb for binding to the RBC membrane (184). Since oxyHb has a 
lower affinity for the membrane than deoxyHb, this would allow more catalase to bind to 
the membrane of RBCs exposed to air.  
It was recently suggested that there is an association between catalase and Prx2 in 
human RBCs (171). Such an association might be important for RBC survival because 
these two proteins could act in synergy, with catalase acting as H2O2 scavenger while 
Prx2 acts as a chaperone for Hb. On the other hand, Prx2 has the ability to metabolize a 
wider range of peroxides than catalase, which only metabolizes H2O2 and very
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 ATPase (194) and Prx2 and catalase might be required at the 
membrane to protect the function of this membrane-associated ATPase. 
Lipid peroxidation products have been reported to accumulate in various tissues 
following hyper-oxygenation (195). Our Western blotting results suggest that Gpx1 
increases at the human RBC membrane after 60 min air exposure. Previous 
photomicrographs recorded in our laboratory also suggest increased Gpx1 membrane 
localization after 60 min air exposure as compared to control (Fig 4.3C vs Fig 4.3I) (163). 
Overall, the combined data from our lab suggest rapid response of Gpx1 to prolonged air 
exposure. Given the critical importance of the RBC membrane, it is not surprising that 




 Appendix 4 
 
Observed densities for Fig 4.2. (A) CuZnSOD, (B) catalase, (C) Prx2, and (D) Gpx1 in membranes isolated from human RBCs 
following air exposure for 0 min, 30 min and 60 min (n=3 individual donors). Proteins were separated by a reducing SDS-PAGE 
(35 µg total protein for CuZnSOD, 30 µg total protein for catalase, Prx2 and Gpx1) and Western blotted. The observed densities of 














































Exp 1 2755.5 2463.2 1788.8 1562.6 2046.7 38.0 48.0 41.0 31.7 46.1 72.4 51.4 43.6 49.3 44.4 
Exp 2 2962.4 2928.4 845.1 1053.0 1142.3 45.4 44.3 38.6 31.9 33.6 65.2 66.2 21.9 33.1 34.0 
Exp 3 2428.2 2137.5 1521.9 1791.1 1894.0 42.3 49.1 44.2 40.2 34.1 57.3 43.6 34.4 44.6 55.5 
                
          Average 65.0 53.7 33.3 42.3 44.6 
          Normalized 1 0.82 0.51 0.65 0.69 
















































Exp 1 1357.9 1310.7 1365.8 1456.9 1581.9 37.0 41.6 31.0 34.1 34.1 36.7 31.5 44.0 42.7 46.5 
Exp 2 1478.7 1257.9 1372.3 1442.8 1980.4 43.4 40.3 33.4 30.8 32.7 34.1 31.3 41.1 46.9 60.5 
Exp 3 1258.7 1214.8 1239.9 1376.8 1485.9 39.4 37.1 35.0 32.0 31.1 32.0 32.8 35.5 43.0 47.8 
                
          Average 34.23 31.83 40.20 44.21 51.54 
          Normalized 1 0.93 1.17 1.29 1.51 
          SEM 0.040 0.014 0.073 0.039 0.132 
(C) Prx2 
NEM 
































Exp 1 1361.5 1147.7 1124.9 1114.6 1562.6 45.7 37.7 28.8 37.7 32.5 29.8 30.4 39.0 29.6 48.1 
Exp 2 1035.6 1027.8 1012.8 1399.3 1352.0 39.8 39.7 51.6 43.0 55.6 26.0 25.9 19.6 32.5 24.3 
Exp 3 1098.9 1120.5 1091.8 1194.5 1223.5 42.5 43.4 33.7 36.9 37.6 25.9 25.8 32.4 32.4 32.5 
                
          Average 27.23 27.38 30.36 31.49 34.96 
          Normalized 1.00 1.01 1.11 1.16 1.28 





















































Exp 1 1110.6 1145.4 1216.8 1134.8 1233.7 36.1 45.9 39.3 30.6 26.1 30.8 24.9 31.0 37.1 47.2 
Exp 2 1211.5 1146.7 1658.7 1129.6 1241.9 43.8 44.3 41.5 35.1 29.5 27.7 25.9 40.0 32.2 42.1 
Exp 3 1045.7 1061.6 1170.4 939.3 1299.7 49.2 33.0 52.5 27.0 35.0 21.3 32.2 22.3 34.8 37.1 
                
          Average 26.58 27.67 31.08 34.68 42.12 
          Normalized 1 1.04 1.17 1.30 1.58 
          SEM 0.105 0.085 0.192 0.054 0.110 
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Statistical significance (*) of differences between 0 min control and air-exposed RBCs 
shown in Fig 5.2 as determined by a Student t-test (unpaired, 2–tailed) with SPSS 
software, p-values ≤0.05 considered significant. Unpaired Student t-test is used when 
there is no need to control for a third confounding variable. The Student t-test was 2-
tailed was used since we are examining differences between control and treated animals 





30 min closed: p = 0.4914 
60 min closed: p = 0.0254* 
30 min open: p = 0.0297* 




30 min closed: p = 0.2012 
60 min closed: p = 0.2488 
30 min open: p = 0.0217* 




30 min closed: p = 0.7234 
60 min closed: p = 0.7665 
30 min open: p = 0.1505 




30 min closed: p = 0.7630 
60 min closed: p = 0.8003 
30 min open: p = 0.0861 









 Chapter 5 Membrane localization of CuZnSOD, catalase, Prx2 and 
Gpx1 in human RBCs on exposure to H2O2 and CHP 
 
5.1 Introduction 
Our interest in the effects of peroxides on localization of antioxidant enzymes in 
RBCs was triggered by reports that CuZnSOD is inactivated by H2O2 (196). Catalase 
almost exclusively metabolizes H2O2 while Prx2 and Gpx1 can metabolize any ROOH 
where the R is hydrogen or an organic group. Prx2 metabolizes H2O2 and ROOH (123, 
197) while Gpx1 has been reported to metabolize H2O2, ROOH, including lipid peroxides 




radicals which are highly reactive and damaging to membranes. Based on their substrate 
selectivity, we hypothesized that catalase, Prx2 and Gpx1 might change localization in 
RBCs in response to challenges with a bolus of H2O2 or ROOH. Thus, to investigate how 
enzyme localization correlates with function, we treated RBCs with a bolus of 50 µM 
H2O2 or 50 µM cumene hydroperoxide (CHP) and isolated the membranes after 30 min. 
Various hydroperoxides have been used to initiate peroxidative mechanisms in 
vitro. CHP, the peroxide used in this study, shows a similar effect to other organic 
hydroperoxides and produces peroxyl radicals, HCOO
●
 (Fig 1.3). Hb is a powerful 
catalyst for the initiation of lipid peroxidation since its iron interacts with peroxides to 
produce reactive radical species via the Harber-Weiss cycle (Fig 1.3) (200). Since CHP is 
known to cause lipid peroxidation (201), we expect to see altered localization for the 





5.2 Results  
The Western blots of CuZnSOD, catalase, Prx2 and Gpx1 after peroxide treatments 
are shown in Fig 5.1. The densitometric analysis of the bands from Fig 5.1 is shown in 
Fig 5.2. 
5.2.1. CuZnSOD localization after peroxide treatment  
Our data suggest that CuZnSOD association with the human RBC membrane is 
unaffected by a bolus of 50 µM H2O2 (Fig 5.2A). H2O2 is not a substrate for CuZnSOD 
which is inactivated by H2O2 (196). In human blood, neutrophils and macrophages 
release 149 µM H2O2 per hour (200) and RBCs are equipped with defences against H2O2 
levels in the 50 µM  used here (Section 2.2.1.3). Peroxides are the by-products of the 
oxidative destruction of foreign matter in these cells. CHP also has no effect on 
CuZnSOD association with the human RBC membrane (Fig 5.2A) although it was 
previously reported that CuZnSOD activity decreased after incubation with CHP in vitro 
(202). 
5.2.2. Catalase localization after peroxide treatment  
It was reported that catalase binds to the RBC membrane via CDB3 (203) and its 
activity decreased upon binding (184). Another group reported that the activity of 
membrane-bound catalase was increased in comparison to cytosolic catalase in human 
RBCs (204). Furthermore, reports of increased catalase activity after incubation of RBCs 
with CHP (202) suggested that catalase might alter its membrane localization after 
treatment with H2O2 or CHP. Surprisingly, the amount of catalase detected at the 
membrane did not change after H2O2 or CHP exposure (Fig 5.2B). This suggests that 
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there is a steady-state population of catalase at the RBC membrane that metabolizes 
H2O2. CHP is not a substrate for catalase, since catalase cannot accommodate ROOH 














Fig 5.1 Western blots of CuZnSOD, catalase, Prx2 and Gpx1 in membranes isolated from human 
RBCs treated with H2O2 or cumene hydroperoxide (CHP), n=3 individual donors. (A) CuZnSOD (B) 
Catalase (C) Prx2 (D) Gpx1. Washed intact human RBCs (500 µL, 3x10
8
 cells/mL) were treated with a 
bolus of 50 µM final concentration of H2O2 (5 µL of 5 mM H2O2), 50 µM final concentration of CHP (5 µL 
of 5 mM CHP) or G-PBS (5 µL, control) as described in Sections 2.2.1.1 and 2.2.1.3. Hypotonic hemolysis 
was performed with 40 mM sodium phosphate buffer, pH 7.4 (Section 2.2.1.4). All tubes were filled to top, 
closed, and gently stirred during incubation at 37 ºC for 30 min. Samples containing 35 µg total protein for 
CuZnSOD, 30 µg total protein for catalase, Gpx1 and Prx2 (Table 3.1) were separated on a reducing SDS-
PAGE. Western blots were visualized by chemiluminescence (Section 2.2.1.8). Lane 1: control; Lane 2: 50 
µM H2O2 (30 min); Lane 3: 50 µM CHP (30 min) 
 














































Fig 5.2 Relative amounts of CuZnSOD, catalase, Gpx1 and Prx2 in membranes isolated from human 
RBCs treated with H2O2 or cumene hydroperoxide (CHP), n=3 individual donors. (A) CuZnSOD (B) 
Catalase (C) Prx2 (D) Gpx1. The Western blots were visualized by chemiluminescence and densitometry 
was performed. Coomassie staining of PVDF membranes after visualization was used as loading control 
(Section 2.2.1.9) and chemiluminescence intensities were normalized by total protein loaded per lane. The 
normalized relative intensities (normalized to control) are shown for each protein ± S.E.M.  
5.2.3. Prx2 localization after peroxide treatment  
Fig 5.1C demonstrates that a fraction of Prx2 is membrane-associated in all samples, 
which is also confirmed by our confocal images in Fig 3.6 and Western blots in Fig 4.2D. 


















































































































































































5.2C). Our experiment (Fig 5.2C) does not distinguish among various Prx2 oligomeric 
states at the RBC membrane, and if there is a change in oligomerization when Prx2 
associates with the membrane, we cannot account for it. Prx2 decreased at the membrane 
after CHP treatment (Fig 5.2C). Since CHP is not a substrate for catalase, CHP may 
induce changes at the membrane that reduce the affinity of Prx2 for the membrane.  
5.2.4. Gpx1 localization after peroxide treatment  
In Fig 5.1D, a fraction of Gpx1 was membrane-associated in all samples. 
Furthermore, Gpx1 increased ~2.5 fold at the membrane after H2O2 or CHP treatment 
(Fig 5.2D). A bolus of H2O2 or CHP can cause lipid peroxidation, which is associated 
with an increase in membrane volume (192) and might recruit Gpx1 to the membrane. 
Thus, Gpx1 may respond to lipid oxidation and may be recruited to the RBC membrane 
because it is an efficient lipid peroxidase (190). 
 
5.3 Discussion 
As shown in Chapter 4, the antioxidant enzymes CuZnSOD, catalase, and Gpx1 
change their localization in response to increased air exposure (Fig. 4.2A,B,D). This 
provides evidence for the response of these enzymes to ROS (178). In this chapter, we 
examined the response of RBC antioxidant enzymes to ROS as discussed in Section 4.1. 
RBCs have efficient enzymes for the decomposition of H2O2 and the best characterized 
ones are catalase, Gpx1 (135) and Prx2. However, CuZnSOD is the only known SOD in 
RBCs, and no change in CuZnSOD localization at the membrane after a bolus of H2O2 or 
CHP was observed here (Fig 5.2A). Catalase also did not change its membrane 
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localization after H2O2 or CHP treatment (Fig 5.2B), but Prx2 decreased after CHP 
treatment (Fig 5.2C) and Gpx1 membrane levels increased ~2.5 fold after H2O2 or CHP 
treatment (Fig 5.2D). 
Western blotting results from Fig 5.1 and their analysis in Fig 5.2 are in 
agreement with previous confocal data obtained for CuZnSOD, catalase and Gpx1 in our 
laboratory and are shown in Fig 5.3 (163). The photomicrographs showing the effects of 
H2O2 on the localization of CuZnSOD, catalase, and Gpx1 in RBCs were obtained by 
generating H2O2 in situ using GOx plus 5 mM glucose which produced H2O2 at 8 
µM/min (163). The results are summarized in Table 5.1. 
 
Table 5.1 Localization of catalase, Gpx1 and CuZnSOD in human RBC after a steady-state 
generation of H2O2. Summary of confocal microscopy results as shown in Fig 5.3. Data was previously 
obtained in our laboratory (163).  
Enzyme G-PBS glucose/GOx glucose/GOx/catalase 
catalase Membrane and cytosol Membrane and cytosol Membrane and cytosol 
Gpx1 Membrane and cytosol Membrane Membrane and cytosol 
CuZnSOD Membrane and cytosol Membrane and cytosol Membrane and cytosol 
 
Confocal photomicrographs revealed that there is no catalase relocalization to the 
RBC membrane after the generation of H2O2 by GOx as compared to images from 
control cells (Fig 5.3B vs A,C) (163). Gpx1 increased its membrane localization after 
H2O2 exposure as compared to control cells (Fig 5.3E vs D,F). CuZnSOD also did not 
change its localization after H2O2 treatment as compared to control cells (Fig 5.3H vs 
G,I). Confocal results (Fig 5.3) agree with Western blotting data (Fig 5.2).  
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Fig 5.3 Confocal immunofluorescence images of CuZnSOD, catalase, and Gpx1 in fixed intact human 
RBCs under H2O2 flux. Data previously obtained in our laboratory (163). A-C.  Catalase stained by sheep 
polycolonal anti-human catalase and Alexa conjugated anti-sheep IgG. D-F. Gpx1 stained by sheep anti-
human Gpx1 and Alexa conjugated anti-sheep IgG. G-I. CuZnSOD stained by rabbit polyclonal anti-human 
CuZnSOD and Cy2 conjugated anti-rabbit IgG. Within 3 h of drawing blood, RBCs at 10% Ht in G-PBS at 
ambient temperature were exposed to 8 µM/min exogenous H2O2 for 9 min. The cells were then stained as 
outlined in Section 2.2.2.2 and 2.2.2.3. Left column, control (5 mM glucose only). Middle column, 5 mM 
glucose plus 1.22 units GOx. Right column, 5 mM glucose plus 1.22 units GOx and 35 nM catalase.  Filter 






























































In contrast, to obtain the Western blotting results, the RBCs were treated with a 
bolus H2O2. Our results in Chapter 4 indicate that air exposure (30 or 60 min) affects 
some antioxidant enzymes (Fig 4.2). A bolus of H2O2 treatment was preferred in this 
thesis, rather than a steady-state H2O2 generation over 9 min, because our aim was to 
minimize RBC air exposure. Also, glucose oxidase (GOx) used for steady-state H2O2 
generation consumes oxygen because the reaction was carried out in closed 2-mL tubes, 
filled to the top.  
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 Appendix 5 
 
Observed densities for Fig 5.2. Relative amounts of (A) CuZnSOD, (B) catalase, (C) Prx2, and (D) Gpx1 in membranes 
isolated from human RBCs treated with H2O2 or cumene hydroperoxide (CHP), n=3 individual donors. Proteins were 
separated by a reducing SDS-PAGE (35 µg total protein for CuZnSOD, 30 µg total protein for catalase, Prx2 and Gpx1) and 

























(A) CuZnSOD Observed density 
 























Exp 1 2503.4 2426.7 2562.4 32.4 32.5 28.5 77.2 74.6 89.9 
Exp 2 3234.4 3141.4 2804.5 52.5 48.5 42.4 61.6 64.8 66.1 
Exp 3 2692.2 2452.6 2204.3 38.7 40.2 33.3 69.5 61.0 66.2 
          
      Average 69.46 66.83 74.08 
      Normalized 1.00 0.96 1.07 














































(B) catalase Observed density 
 























Exp 1 1456.3 1462.5 1398.6 52.5 50.5 52.5 27.7 28.9 26.6 
Exp 2 1342.0 1299.6 1189.6 37.8 43.6 38.8 35.5 29.8 30.6 
Exp 3 1438.5 1398.4 1405.7 45.5 48.6 43.4 31.6 28.8 32.4 
          
      Average      31.63    29.18       29.88  
      Normalized        1.00    0.92         0.94  




























Exp 1 1606.4 1251.7 1178.9 59.4 37.4 48.6 27.0 33.5 24.3 
Exp 2 1123.5 1064.5 893.0 36.9 33.6 34.9 30.4 31.7 25.6 
Exp 3 1080.0 1089.3 702.4 34.6 35.8 34.6 31.2 30.4 20.3 
          
      Average 29.55 31.86 23.40 
      Normalized 1.00 1.08 0.79 































(D) Gpx1 Observed density 
 























Exp 1 1186.7 1296.8 1626.5 48.7 23.2 31.1 24.4 56.0 52.3 
Exp 2 546.5 1095.5 1153.5 25.7 19.1 22.0 21.3 57.4 52.4 
Exp 3 353.0 864.3 989.8 17.7 18.7 21.9 19.9 46.2 45.2 
          
      Average 21.86 53.19 49.97 
      Normalized 1.00 2.43 2.29 





 Chapter 6: Membrane localization of RBC antioxidant proteins in 
a diabetic rat model 
6.1 Introduction 
Diabetes is a disease associated with enhanced ROS generation in RBCs (80). 
Thus, we predicted a change in the recruitment of antioxidant enzymes to the diabetic 
RBC membrane to offset the effects of increased ROS. We induced diabetes in rats with 
streptozotocin (STZ) and monitored the levels of membrane-associated antioxidant 
enzymes in control and diabetic animals by Western blotting.  
In Chapters 4 and 5, RBCs were treated with air, H2O2 and CHP for relatively 
short times (30 or 60 min). In this chapter we are investigating the long-term effects (4 
weeks) of STZ-induced diabetes on the localization of antioxidant enzymes. Rat RBCs 
have a lifetime of ~60 days (205), while human RBCs have a lifetime of ~120 days (10). 
Thus, the diabetic RBCs used this study are not only aging (28 days) but are also 
subjected to dramatically increased glucose levels during their lifetime. 
Western blotting and confocal data show that increased amounts of catalase and 
Gpx1 were recruited to the membrane whereas Prx2 remained unchanged in normal 
human RBCs exposed to air for 60 min (Fig 4.2B, C, D). CuZnSOD decreases at the 
membrane and re-localizes to the biconcave surface (Fig 4.2A). Based on such 
observations, we hypothesized that recruitment of different antioxidant enzymes is 
necessary to protect the membrane from various ROS. We speculated that loss of RBC 
membrane recruitment of antioxidant enzymes would make the membrane more 
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susceptible to damage. This damage would impair RBC function and likely contribute to 
the long-term vascular complications, such as those associated with diabetes (206).  
Many proteins bind to CDB3 (15), and this binding can be controlled by CDB3 
phosphorylation (186). When isolated RBC membranes were incubated in the presence of 
[γ-32P]ATP, about 80% of the label was found in the N-terminal residues (1–56) (185). 
Thus, phosphorylation of the RBC membrane occurs mainly at CDB3 and 50-70% of the 
phosphorylation was observed at Tyr8 (26). Tyr21 and Tyr46 are also phosphorylated but 
to a lesser extent and the membrane-spanning fragment of Band-3 has no phosphorylation 
sites (185).  
PTP1B is the main phosphatase at the RBC membrane (186). Changes in PTP1B 
activity were reported to occur in various tissues after 20-day STZ treatment. For 
example, PTP1B activity increased by 70% in the placenta, decreased by 40-50% in liver 
and skeletal muscle but remained unchanged in kidney and brain (207). There are no 
reports of PTP1B activity in diabetic RBCs, which undergo increased oxidative stress 
(80). This could lead to PTP1B inactivation by oxidation of its redox-sensitive catalytic 
Cys residue. Thus, we hypothesized that CDB3 phosphorylation may regulate binding of 
some antioxidant enzymes to the RBC membrane.  
 
6.2 Results   
6.2.1. CuZnSOD localization in diabetic RBCs  
CuZnSOD increased at the RBC membrane of control animals in a 2-week period 
(no STZ treatment, Fig 6.2A). We also measured PTPase activity of the RBC membranes 
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(Fig 6.3) and found an increase over the same period (Fig 6.3). Increased PTPase activity 
likely results in decreased phosphorylation of CDB3, which we attribute to the increase 
of CuZnSOD at the RBC membrane of control animals. 
There was a significant increase in CuZnSOD at the RBC membrane in STZ-
treated animals, as compared to control, 2 weeks after the induction of diabetes (Fig 
6.2A). However, no significant increase in PTP1B activity between STZ-treaated and 
control RBCs was found 2 weeks after the induction of diabetes (Fig 6.3) raising the 
possibility that CuZnSOD is recruited to the membrane by altered CDB3 phosphorylation 
in diabetic RBCs. Also, non-specific binding of CuZnSOD to the membrane, via 
crosslinking for example, might be caused by increased oxidative stress associated with 
diabetes. There was a decrease in the levels of CuZnSOD at the membrane after 4 weeks 
of STZ treatment compared to 2 weeks of STZ treatment (Fig 6.2A), and we speculate 
that CuZnSOD might be competing with hemichromes or Prx2 for the RBC membrane in 
the 4-week diabetic RBCs. 
6.2.2. Catalase localization in diabetic RBCs  
RBCs from STZ-treated rats are expected to behave as cells from older animals 
because diabetes exacerbates RBC aging (208). The levels of membrane-associated 
catalase significantly decreased in the STZ-treated animals 4 weeks after the induction of 
diabetes as compared to RBCs exposed to elevated glucose for 2 weeks (Fig 6.2B). 
Elevated levels of metHb have been reported in diabetic RBCs (209). Since metHb is a 
precursor of hemichromes, catalase might compete with accumulation of irreversible 
hemichromes in diabetic RBCs 4 weeks after the induction of diabetes. Diabetes for 4 
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weeks likely induces more hemichrome formation, which would explain why the 
decrease observed between 2- and 4-weeks after treatment is more pronounced than the 
decrease in control RBCs.  
6.2.3. Prx2 localization in diabetic RBCs  
As discussed in Section 1.3 (Fig 1.3), hemichromes formation can be reversible or 
irreversible. Reversible hemichromes can be converted back to metHb, and eventually to 
reduced Hb. If irreversible hemichromes (bishistidine ferrihemochromes for e.g.) are 
formed, the Hb denaturation cannot be reversed and the RBCs are removed from 
circulation (61). In Fig 6.2C, there is an initial large increase in membrane-associated 
Prx2 2 weeks after STZ treatment as compared to the control. At this point, reversible 
hemichrome formation might be occurring and concomitant hemichrome association with 
the membrane. Thus, Prx2 would migrate to the RBC membrane to rescue the reversible 
hemichromes in the 2-week diabetic RBCs. However, after 4 weeks, membrane-
associated Prx2 approaches control levels. At this point the RBCs probably contain an 
increased population of irreversible hemichromes at the membrane and Prx2 is unable to 
rescue them. Overall, the variation of catalase and Prx2 levels at the membrane suggests 
that Prx2 protects Hb from denaturation in diabetic RBCs and catalase likely associates 
with Prx2 as previously reported (171).  
6.2.4. Gpx1 localization in diabetic RBCs  
Gpx1 is an efficient lipid peroxidase (188). Thus, it is critical that its membrane 
levels are maintained to protect membrane lipids. Fig 6.2D shows only small diabetes-
induced changes in Gpx1 membrane localization, indicating that the Gpx1 interaction 
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with the membrane is relatively robust. Such behaviour is expected since Gpx1 needs to 
stay at the membrane to protect lipids in older cells, as it is necessary to protect against 
Hb leakage and hemolysis. Lysis of old RBCs is as detrimental as lysis of young RBCs 
because Hb is released into plasma in both cases. Since lipids are found uniformly 
throughout the RBC membrane, we did not expect to see Gpx1 competing with 
















Fig 6.1 Western blots for CuZnSOD, catalase Prx2 and Gpx1 in isolated membranes from rat RBCs. 
(n = 5 animals). Rat membranes were prepared as described in Sections 2.2.1.5 and 2.2.1.6. Lanes 1 – 5 
are STZ-treated animals and lanes 6 – 10 are control animals. RBCs were washed twice in isotonic 
physiological saline solution (PSS, pH 7.4), lysed and membranes were washed three times in 10 mM 
hypotonic sodium phosphate buffer, pH 7.4 (1:15 dilution) containing 0.1 mM PMSF at room temperature 
(Section 2.2.1.6). The non-ionic detergent 0.5% Triton-X was added to the pellet to solubilize the proteins. 
Proteins were separated by a reducing SDS-PAGE and immunoblotted (Section 2.2.1.7). 35 µg total protein 
per lane was loaded for CuZnSOD and Gpx1 and 30 µg total protein for catalase and Prx2. Densitometry 
results are shown in Fig 6.2 after correction with the loading control and normalization to 2-week control 
(Section 2.2.1.9). 
(B) 4 weeks after STZ injection 
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Fig 6.2 Densitometry of CuZnSOD, catalase, Prx2 and Gpx1 bands in Western blots from control 
and STZ-treated rat RBCs after removal of outliers. Densitometry was performed on the Western blots 
shown in Fig 6.1. (A) CuZnSOD (B) Catalase (C) Prx2 (D) Gpx1. Statistical significance (*) of differences 
among controls and STZ-treated animals was determined by Student t-test (unpaired, 2–tailed) using SPSS 
software and p-values ≤ 0.05 were considered significant. The 2-tailed t-test is used when examining 
significant differences between two groups without prior assumptions which group would be higher (or 
lower). Unpaired Student t-test is used when there is no need to control for a third confounding variable. 
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Fig 6.3 Comparison of PTP1B activity in membrane fractions from diabetic and normal rat RBCs. 
PTPase activity was determined using p-nitrophenyl phosphate (p-NPP) as substrate according to published 
procedures (210) with some modifications. The non-specific substrate p-NPP is used for determination of 
overall PTPase activity. Since PTP1B is the main phosphatase at the RBC membrane (186), we assume that 
PTP1B activity is being measured here. Membranes from rat RBCs were washed and isolated as described 
in Sections 2.2.1.5 and 2.2.1.6, diluted into 25 mM HEPES with 20 mM MgSO4, pH 7.4 at room 
temperature, 1 mM DTT was added followed by 15 mM p-NPP (all concentrations are final), and the 
mixture was incubated for 30 min at 37 ºC. The reaction was stopped with 0.1 mM NaOH, the samples 
were vortexed briefly and centrifuged at 8000 xg. Supernatants were collected and the OD at 405 nm was 
measured to determine the average PTP1B activity over 30 min. All data are normalized to the 2-week 
control. The average of n=5 animals + SEM shown for (A) 2-week STZ treatment and n=4 for (B) 4 weeks 
after STZ treatment.  
 
6.3 Discussion 
STZ treatment accelerates CuZnSOD, catalase, and Prx2 loss from the rat RBC 
membrane as revealed by their analysis at 2 vs 4 weeks after STZ treatment (Fig 
6.2A,B,C). Elevated levels of metHb have been reported in diabetic RBCs (209) and 

































































since metHb is a precursor of hemichromes, these three enzymes might be competing 
with increased hemichrome formation for CDB3 binding sites as the disease progresses. 
Gpx1 membrane levels in the control and diabetic rat RBCs are the same during 
our observation period (Fig 6.2D). Since we anticipated that the increased oxidative stress 
induced by diabetes (80) would saturate the Gpx1 binding sites at the RBC membrane, it 
appears that these sites are also fully saturated in the control animals. This would imply 
that the lipid peroxidase activity of Gpx1 is of critical importance in maintaining the 
integrity of the RBC membrane. 
Band-3 is a major substrate for kinases at the RBC membrane (211). Several 
PTPases have been detected in the RBC cytosol (212) but PTP1B is the main membrane-
associated PTPase that dephosphorylates Band-3 (186). We hypothesized that increased 
oxidative stress in the RBCs of diabetic rats (80) would lead to increased CDB3 
phosphorylation due to PTP1B inactivation on oxidation of its catalytic cysteine. Thus, to 
investigate a possible role for Band-3 Tyr phosphorylation in the localization of 
antioxidant enzymes, we measured the total PTPase activity, which largely reflects 
PTP1B activity, in ghost membranes from rat RBCs.  
We observed no significant difference in PTPase activity between STZ-diabetic 
and control RBCs (Fig 6.3). However, in untreated animals, the PTPase activity increased 
significantly in a 2-week interval (Fig 6.3). Thus, we speculate that the 50% increase in 
CuZnSOD at the RBC membranes during this interval (Fig 6.2) may be due to less Tyr8, 
Tyr21, and/or Tyr46 phosphorylation at CDB3. The remarkable alteration in PTPase 
activity observed during a 2-week interval in 3-month-old untreated rats suggests that the 
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animals are responding to other factors in their environment separate from the STZ 
challenge.  
Notably, the levels of catalase, Prx2 and Gpx1 associated with the membrane do 
not change with PTPase activity. This suggests that recruitment of these antioxidant 
proteins to CDB3 is independent of its phosphorylation status and, as mentioned above, 




 Appendix 6 
Observed densities for Fig 6.2 Densitometry of CuZnSOD, catalase, Prx2 and Gpx1 bands in 
Western blots from control and STZ-treated rat RBCs (n=5). Proteins were separated by a reducing SDS-
PAGE (35 µg total protein for CuZnSOD, 30 µg total protein for catalase, Prx2 and Gpx1) and Western 
blotted. The observed densities of WB bands and loading control are shown below. The shaded values 































































































Statistical significance (*) of differences between samples shown in Fig 6.2 were 
determined by a Student t-test (unpaired, 2–tailed) with SPSS software, p-values ≤0.05 
considered significant. Unpaired Student t-test is used when there is no need to control 
for a third confounding variable. The Student t-test was 2-tailed was used since we are 
examining differences between control and treated animals without initial assumptions 




Control 2 wks vs STZ-treated 2 wks: p = 0.0002* 
Control 4 wks vs STZ-treated 4 wks: p = 0.1148 
Control 2 wks vs Control 4 wks: p = 0.002* 
STZ-treated 2 wks vs STZ-treated 4 wks: p = 0.0229* 
STZ treated 2 wks vs Control 4 wks: p = 0.0127* 




Control 2 wks vs STZ-treated 2 wks: p = 0.3431 
Control 4 wks vs STZ-treated 4 wks: p = 0.0121* 
Control 2 wks vs Control 4 wks: p = 0.0688 
STZ-treated 2 wks vs STZ-treated 4 wks: p = 0.0126* 
STZ treated 2 wks vs Control 4 wks: p = 0.0657 




Control 2 wks vs STZ-treated 2 wks: p = 0.0001* 
Control 4 wks vs STZ-treated 4 wks: p = 0.0512* 
Control 2 wks vs Control 4 wks: p = 0.933 
STZ-treated 2 wks vs STZ-treated 4 wks: p = 0.3618 
STZ treated 2 wks vs Control 4 wks: p = 0.0114* 




Control 2 wks vs STZ-treated 2 wks: p = 0.0429* 
Control 4 wks vs STZ-treated 4 wks: p = 0.0001* 
Control 2 wks vs Control 4 wks: p = 0.7783 
STZ-treated 2 wks vs STZ-treated 4 wks: p = 0.0864 
STZ treated 2 wks vs Control 4 wks: p = 0.0009* 




 Chapter 7: Overall discussion and conclusions 
We examined the localization in RBCs of CuZnSOD, catalase, Prx2 and Gpx1 to 
gain insight into their function. We examined prompt RBC responses on oxidant 
challenge vs the effects of diabetes over 4 weeks.  
In Chapters 4 and 5, we report on the prompt changes in human RBCs upon 
challenge with air, H2O2 and CHP. Exposure to air for 30 or 60 min should have similar 
effects on RBCs as hyperbaric challenge. As RBCs pass through the lungs, they are 
exposed to O2 for only a few seconds so exposing RBCs to ambient air for an extended 
period of time (30 or 60 min) should mimic exposing RBCs to higher O2 partial pressures 
in the vasculature. Exposure to peroxides was also short-term (30 min). Chapter 6 
examines long-term changes occurring in rat RBCs exposed to increased plasma glucose 
levels over a 4-week period. Specifically, we investigated the association of CuZnSOD, 
catalase, Prx2, and Gpx1 with the RBC membrane. Based on the literature, we assume 
CDB3 to be their major binding site. Diabetes causes major changes in RBCs, including 
hemichrome formation (213) and decreased PTP1B activity (207, 214)  
The data obtained on control rats suggest that CDB3 phosphorylation may 
regulate CuZnSOD membrane binding. CuZnSOD increased its membrane localization in 
rat RBCs during a 2-week interval (Fig 6.2A), which correlates with loss of PTPase 
activity (Fig 6.3). CuZnSOD also decreased its membrane localization after 60 min 
aeration (Fig 4.2A) but PTPase activity was not monitored under these conditions. 
Catalase significantly increased at the membrane after 30 min air exposure and 










¯, which is rapidly dismutated to H2O2. Possible increased H2O2 
generation at the membrane may trigger catalase migration to protect the membrane. In 
contrast, membrane-associated catalase changed slightly over a 2-week period in control 
rat RBCs (Fig 6.2B) but STZ treatment accelerated loss of this enzyme from the 
membrane as revealed by the blots at 4 vs 2 weeks after induction of diabetes (Fig 6.2B). 
As mentioned in Section 6.3, we attribute this to the possible increase in hemichrome 
formation.  
Prx2 is likely recruited to the membrane to act as a chaperone and rescue reversible 
hemichromes to prevent their conversion to irreversible forms. Prolonged air exposure 
does not alter Prx2 levels at the human RBC membrane (Fig 4.2C), presumably because 
hemichrome formation is a slow and gradual process (213). However, diabetes 
accelerates the aging process such that Prx2 membrane localization increased 2 weeks 
after STZ treatment but irreversible hemichrome formation as diabetes progresses likely 
results in a loss of Prx2 from the membrane (Fig 6.2C).  
Gpx1 membrane levels in diabetic and control RBCs remain unchanged between 2 
and 4 weeks (Fig 6.2D), but 60 min air exposure triggers increased Gpx1 recruitment to 
the RBC membrane (Fig 4.2D). We speculate that all Gpx1 binding sites at the membrane 
are saturated in rat RBCs due to the additional oxidative stress induced by diabetes. 
However, Gpx1 in human RBCs promptly responded to an acute stress such as 60 min air 
exposure (Fig 4.2D) by moving to the membrane to protect the lipids from oxidation. We 
speculate that oxidized lipids, which undergo an increase in volume (190), recruit Gpx1, 
which is a highly efficient lipid peroxidase.  
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Based on the results presented in this thesis, we suggest some possible studies of 
current blood storage practices, which cause “storage lesions” associated with oxidative 
stress (75). Storage of blood under hypobaric conditions should be investigated as should 
the use of low molecular weight SOD mimetics (215). Modulation of PTPase activity and 
hemichrome formation should be investigated as we speculate that they control 
recruitment of antioxidant enzymes to the RBC membrane.  
Finally, we note that the results in this thesis were mainly acquired by semi-
quantitative Western blotting. Confocal microscopy is a highly complementary technique 
for determining protein localization within cells. While low-affinity interactions can be 
disrupted during RBC handling and membrane isolation prior to Western blotting, such is 
not the case with confocal microscopy, which can be quantitative and also provides 
important spatial information depending on the image collection conditions (controls vs. 




 Chapter 8: Future studies 
Many interesting results reported in this work need further investigation. Below are 
some suggestions, separated into experiments to be performed by biochemical techniques 
and by confocal microscopy. 
Biochemical techniques:  
1) Measure PTPase activity in membrane fractions after 60 min air exposure. To 
confirm our hypothesis that PTP1B regulates CuZnSOD membrane-binding in 
RBCs, we expect to see a decrease in PTPase activity in membrane fractions after 
60 min air exposure.  
2) Also, measure PTPase activity in H2O2-treated and CHP-treated RBCs and 
correlate this with the drop in CuZnSOD at the membrane after prompt stress 
(H2O2, CHP). 
3) Determine phosphorylation of CDB3 in RBCs by anti-phosphotyrosine antibody. 
4) Measure the activity of CuZnSOD, catalase, Prx2, and Gpx1 in RBC membranes 
and cytosolic fractions to validate the data obtained by Western blotting and 
confocal microscopy. Differences in activities at the membrane and in the cytosol 
would provide further insight into the precise function of the antioxidant proteins. 
Prx2, catalase and Hb were reported to interact in cytosol of stored RBCs (171). 
No Prx2 peroxidase activity was found in association with both catalase and Hb 
(171), indicating that Prx2 is acting as a chaperone for Hb. However, when in 
association with catalase at the membrane, Prx2 was reported to exhibit 
peroxidase activity (171). 
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5) Investigate hemichrome formation in RBCs under oxidative stress by electron 
paramagnetic resonance (EPR).  
Confocal microscopy:  
1) Confocal micrographs have been obtained in our laboratory for CuZnSOD, 
catalase, and Gpx1 after 60 min air exposure. To obtain a complete dataset, 
confocal photomicrographs for Prx2 after 60 min air exposure should  be 
obtained.  
2) Confirm CDB3 binding sites by competition between anti-CDB3 antibody and 
antioxidant proteins. A monoclonal anti-CDB3 antibody, which recognizes an 
epitope within residues 1-136 of CDB3 was used (161). If two proteins colocalize 
or their locations are very close, their antibodies would have to compete for 
binding within a limited space. Hence, antibody binding to one protein should 
hinder antibody binding to the second protein. Competition between anti-
CuZnSOD and anti-CDB3 was performed previously in our group and we found 
that CuZnSOD binds at or near the N-terminus of CDB3 (149, 163). Competition 
between anti-catalase (or anti-Gpx1, anti-Prx2) and anti-CDB3 binding needs to 
be performed to confirm the membrane binding sites of these antioxidant proteins. 
Also, the effect of treatment and aging on anti-CDB3 binding to CDB3 is of 
interest since hemichrome formation may compete with the antibody for its 
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